政大機構典藏-National Chengchi University Institutional Repository(NCCUR):Item 140.119/153126
English  |  正體中文  |  简体中文  |  Post-Print筆數 : 27 |  Items with full text/Total items : 113318/144297 (79%)
Visitors : 51023947      Online Users : 865
RC Version 6.0 © Powered By DSPACE, MIT. Enhanced by NTU Library IR team.
Scope Tips:
  • please add "double quotation mark" for query phrases to get precise results
  • please goto advance search for comprehansive author search
    •  Adv. Search
    Home ‧ Login ‧ Upload ‧ Help ‧ About ‧ Administer Goto mobile version


    Please use this identifier to cite or link to this item: https://nccur.lib.nccu.edu.tw/handle/140.119/153126


    Title: 企業智慧財產權競合策略與價值轉化
    Corporate Intellectual Property Rights Co-opetition Strategy and Value Transformation
    Authors: 梁煥煒
    Liang, Huan-Wei
    Contributors: 吳豐祥
    Wu, Feng-Shang
    梁煥煒
    Liang, Huan-Wei
    Keywords: 競合策略
    智慧財產權策略
    動態能力
    價值創造
    價值轉化
    智財選擇權策略
    專利管理
    Coopetitive strategy
    Intellectual property strategy
    Dynamic capabilities
    Value creation
    Value transformation
    Strategy options of intellectual property rights
    Patent management
    Date: 2024
    Issue Date: 2024-09-04 13:58:50 (UTC+8)
    Abstract: 從合作轉競爭兩種路徑，並觀察其反覆轉變關係的動態過程。每個案例有其不同特色及運作機制，例如，競爭與合作多次反覆、第三方角色、無效化專利策略、轉用競爭者IP及能力、槓桿競爭結構、不打不相識、借力使力及化敵為友等等。
    藉由案例的分析及與學理的結合，本研究提出「IPR競合策略與價值轉化模型」，主要研究結論如下：
    一、智財競合的關鍵內涵包括企業所處市場、智財動態能力、智財策略選擇權、關係轉變及價值轉化等五部分。
    智財競合指企業與競爭者及合作者間，於產品市場及技術市場，因IPR活動產生競爭行為，改變組織關係，包括從合作轉競爭，及從競爭轉合作。企業運用智財動態能力及智財策略選擇權，發揮IPR影響力改變賽局，進而能掌握機會，使雙方在技術市場或產品市場進行合作，帶來價值轉化的效益，達成雙贏。
    二、企業所處的「動態環境」會與IP特性，共同驅動IPR競合活動及增加企業關係的動態性，且會促進企業關係變動的循環。
    企業的「動態環境」包括企業關係環境及外部環境，會結合IP特性（營業秘密保護之不確定性、專利專屬性、被第三人舉發專利有效性、技術授權契約定義解釋的模糊性及履約不確定性），使企業關係變得更為動態。加上競爭本質的驅動，使企業在IPR競合過程會呈現「競爭—合作—競合」的動態循環。
    三、企業會向外部第三方取得關鍵IPR及策略經驗，並運用第三方的智財動態能力，以提高本身與競合者對抗之能力。
    當企業缺乏足夠的IPR資源，特別是小企業，可向外部第三方（如律師、專家、科研機構及企業等對象）尋求協助，運用其智財動態能力，增加IPR策略的影響效力。因此，第三方角色會影響IPR競合雙方決策。若第三方有不適宜的情形，企業也需立即調整與更換。
    四、企業在IPR競合中，會透過雙元思維、專利的品質與價值之有效性判斷，並運用專利二元專屬性做為合作媒介，來促進價值轉化。
    競爭者能分析專利品質與價值，及具有雙元思維（如運用對方的專利及IP能力，或讓自己的專利及IP能力為對方所用）及瞭解專利的二元專屬特性（以專利向對方提告，也可用來保護對方的產品），可更靈活地運用IPR策略，而有機會以高品質及高價專利做為建立競合關係的媒介，創造與轉化不同價值。
    五、企業與合作夥伴的營業秘密賽局會驅動IPR競合，企業並會透過智財動態能力來即時偵測營業秘密外洩、蒐證及主張權利，產生多元合作模式。
    企業IPR合作存在兩難情境，企業需揭露重要技術資訊予合作夥伴，以利研發合作，卻難以管控夥伴結束合作後不當使用營業秘密之行為，使合作轉為競爭。企業需要運用智財動態能力，如人脈網絡、員工離職保密制度、資料還原及網路使用紀錄之偵測技術、專利分析及司法蒐證等等方式，找出營業秘密外洩證據。營業秘密案最後的合作方式，包括合作開發、產能支援及入股成為股東。
    六、智財動態能力及智財策略選擇權具有相互配合與支持之關係，企業能用以形塑競合關係，達到策略經濟與強化管理競合關係之效益，並帶來價值轉化效益。
    企業在有限的資源條件下，可運用智財動態能力促進IPR資源的流動，找出對的IPR及IPR策略，調整智財策略選擇權範圍，發揮以小搏大的槓桿效益，以做有效的商業談判，轉變企業關係，也能用以建立、維繫及運作與競合者合作的管理機制、契約與條件。藉此，企業能進一步透過價值轉化（包括重新結構、增加、減少、融合、轉換、轉用及轉型等模式），帶來實際效益及降低潛在價值流失的風險（包括價值破壞、成本支出的增加及價值創造的失效等等）。
    七、企業的IPR競合心態會影響其在競合過程中的IPR策略、競爭者行為及合作關係的建立。
    本研究案例呈現企業在IPR競合過程，企業主於競爭及協商中會出現不同的心態，進而影響IPR訴訟策略、競爭者行為、談判效果及企業關係建立。企業的IPR競合心態包括企業主意志、環境因素（文化及利害關係人（律師、IP法務長及第三方等等））及「雙向思維」等等部分。其中，企業具有「雙向思維」，能同時進行不同邏輯之行為，及以綜觀全局的角度考量自己與競爭者雙方之需求、資源、溝通與關係，提出雙贏方案。
    八、企業在IPR競合的過程中，會透過智財動態能力的建立，來主導與競合者的關係轉變，以獲取比競爭者更大的影響力。
    IPR競合常出現「不打不相識」及IPR資源內外部流動之特色，企業要在IPR競合掌控關係轉變的主導優勢，需以智財動態能力運用IPR資源及策略，以與競爭者談判及交換條件，否則競爭者不會與之合作。企業愈具有高階智財動態能力，愈有影響IPR競合關係的優勢。若企業缺乏轉變關係或抵抗轉變關係的能力，形同於企業關係中處於被動，易遭競爭者擺弄與破壞契約關係，而不利價值獲取。
    本研究主要帶來四項學術上的貢獻，包括：提出智財動態能力的概念，延伸了動態能力於IPR競合領域的應用；IPR競合策略的豐富案例研究，擴充了競合研究有關IPR競合研究之領域；提出智財策略選擇權概念，擴大了實質選擇權於IPR策略之應用範圍；及有關智財動態能力及智財策略選擇權交互影響的發現，豐富了IPR策略的實證及組織疆界定義之理論。本研究最後並提出實務上及未來研究上的建議。
    Since Brandenburger and Nalebuff (1995) proposed coopetition strategy, the study of cooperation between corporations and competitors has received long academic attention. However, there are still limited explanatory perspectives on how and why inter-corporation competition, cooperation, and coopetition transform in dynamic and uncertain situations.
    On the other hand, there has been little research on how companies use intellectual property rights (IPR) to manage, influence and control their relationships with competitors, resulting in a lack of insights that are both academically and practically inspiring. Several IPR strategies have been proposed, such as proprietary, defensive, and leveraging strategies (Somaya, 2012), which have been developed for use in a variety of competitive contexts. Recently, Trigeorgis, Baldi, and Makadok (2022), based on the concept of “real option”, advocate that corporations can change the competitive, cooperative, and competing strategies of patent layout according to the situation in order to obtain innovation performance. However, they do not have sufficient explanations and illustrations of the practical application of IPR strategies and the nature of IP, which makes their theoretical perspective need to be further tested and revised.
    Furthermore, while past research on dynamic capabilities has focused on how corporations integrate and coordinate internal and external resources in response to environmental changes (Teece, 2007; Teece, Pisano, & Shuen, 1997), more recent scholars have also explored how dynamic capabilities affect coopetitive relationships (Teece, 2019; Zulu-Chisanga, Oghazi Hultman, Leonidou, & Boso, 2023). However, there is still a lack of research on how corporations utilize dynamic capabilities to influence the change process of corporations in competition, cooperation, and coopetition.
    By synthesizing the above three academic lines, this study can find an important research gap: how corporations can utilize intellectual property rights to influence the changes between competitive, cooperative and coopetitive relationships, and bring different values. To this end, the main objective of this study is to explore the complexity, dynamics and value transformation of the IPR coopetition process in depth by adopting a qualitative research methodology. Focusing on patent issue and including cases involving both patents and trade secrets, this study analyzes 10 cases of IPR coopetition, including biotechnology, pharmaceuticals, semiconductors, gaming, robotics, and optical lenses, through interviews with key participants and collect secondary data collection, to explore why and how companies use IPR coopetition strategies to create win-win situations and value creation. It includes analyzing the two paths of corporations from competition to cooperation and from cooperation to competition, and observing the dynamic process of their repeated relationship changes. Each case has its own characteristics and operating mechanisms, such as repeated repetitions of competition and cooperation, the role of third parties, invalidating patent strategies, diversion of competitors' IPR and capabilities, leveraged competition structures, no fight, no acquaintance, leveraging competitor’s strengths into power, and turning enemies into friends, and so on.
    By analyzing the cases and combining with the theories, this study proposes the “IPR Coopetition Strategy and Value Transformation Model”, and the main conclusions of the study are as follows:
    I. The connotation of IPR coopetition consists of five parts: the market in which the corporation is located, dynamic capability of intellectual property rights (IPDC), strategy options of intellectual property rights (IPSO), relationship changes and value transformation.
    IPR coopetition refers to the competitive behavior between corporations and their competitors and partners in the product market and technology market due to IPR activities, which changes the organizational relationship, including the change from cooperation to competition, and the change from competition to cooperation. Corporations utilize their IPDC and IPSO to change the game by leveraging their IPR influence, and then grasp the opportunities to cooperate in the technology market or product market, bringing value transformation benefits and achieving a win-win situation.

    II. The “dynamic environment” in which a corporation operates will, together with IP characteristics, drive IPR coopetition activities and increase the dynamics of corporate relationships, as well as contribute to the cycle of change in corporate relationships.
    The “dynamic environment” of corporations includes the environment of corporate relationship and external environment, which will combine with the IP characteristics (e.g., uncertainty of trade secret protection, patent specificity, validity of patents invoked by third parties, ambiguity of the interpretation of the definition of technology licensing contract, and uncertainty of performance) to make the corporate relationship become more dynamic. In addition, the competitive nature of corporations will lead to a dynamic cycle of “competition-cooperation-competition” in the process of IPR coopetition.

    III. Corporations can obtain key IPR and strategy experience from external third parties, and utilize the IPDC of third parties to enhance their ability to compete with competitors.
    When corporations lack sufficient IPR resources, especially small corporations, they can seek assistance from external third parties (e.g., lawyers, experts, research organizations, and targets such as corporations) to utilize their IPDC to increase the impact effectiveness of their IPR strategies. Therefore, the role of the third party can influence the decision-making of both IPR coopetitors. If the third party is unsuitable, the corporation needs to adjust and replace it immediately.

    IV. In IPR coopetition, corporations will utilize dualistic thinking, judge the quality and value of patents, and utilize the ambidextrous appropriation of patents as a medium of cooperation to promote the transfer of value.
    Competitors who are able to analyze the quality and value of patents, and have dualistic mindset (e.g., using the other party's patents and IP capabilities, or letting their own patents and IP capabilities to be used by the other party) and understand the ambidextrous appropriation characteristics of patents (using patents to file lawsuits against the other party, or using patents to protect the other party's products) can use IPR strategies more flexibly and have the opportunity to use high-quality and high-priced patents as a medium to establish a coopetitive relationship, creating and transforming different values.

    V. The trade secret competition game between corporations and partners will drive the IPR coopetition, and corporations will realize multiple cooperation modes through the ability of IPDC to detect trade secret leakage, collect evidence and claim rights in real time.
    There is a dilemma in IPR cooperation. Corporations need to disclose important technical information to partners to facilitate R&D cooperation, but it is difficult to control the misuse of trade secrets by partners after the end of cooperation, which will turn cooperation into competition. Corporations need to utilize IPDC, such as network of contacts, confidentiality system for employee termination, data recovery and detection of network usage records, patent analysis and judicial evidence collection to find out the evidence of trade secret leakage. The final cooperation in trade secret cases include joint development, production support, and becoming a shareholder.

    VI. IPDC and IPSO have a mutually complementary and supportive relationship, which can be used by corporations to shape coopetitive relationships, achieve strategic economic and strengthen the management of coopetitive relationship benefits, and bring value transformation benefits.
    With limited resources, a corporation can utilize its IPDC to facilitate the flow of IPR resources, identify the right IPR and IPR strategies, adjust the range of IPSO, and leverage the power, in order to conduct effective business negotiations, transform corporate relationships, and also establish, maintain and operate management mechanisms, contracts and conditions for cooperation with competitors. By doing so, corporations can further transform value (including restructuring, adding, subtracting, integrating, converting, repurposing, and transforming) to deliver substantial benefits and mitigate the risk of potential value loss (including value destruction, increased costs, and failures in value creation).

    VII. A corporation's IPR coopetition mindset affects its IPR strategy, competitor behavior, and cooperative relationship building during the competition process.
    This case study demonstrates that in the IPR coopetition process, entrepreneurs have different mindsets in competition and negotiation, which in turn affect IPR litigation strategies, competitor behavior, negotiation effects, and corporate relationship building. A corporation's IPR coopetition mindset includes the entrepreneur's will, environmental factors (culture and stakeholders (lawyers, IP attorneys, third parties, etc.)), and “two-way thinking”. In particular, a corporation with “two-way thinking” is able to act with different logics at the same time, and to consider the needs, resources, communication and relationship between itself and its competitors from a holistic perspective, in order to come up with a win-win solution.

    VIII. In the process of IPR coopetition, corporations will lead the change of relationship with competitors through the establishment of IPDC in order to gain more influence than competitors.
    IPR coopetition is often characterized by “no fight, no acquaintance” and the internal and external flow of IPR resources. In order to control the dominant advantage in IPR coopetition, corporations need to utilize IPR resources and strategies with IPDC to negotiate and exchange terms with competitors, otherwise competitors will not cooperate with them. The more advanced IPDC a corporation has, the more advantage it has in influencing IPR coopetitive relationships. If a corporation lacks the ability to change relationships or resist changing relationships, it will be passive in its relationships and vulnerable to competitors' manipulation and disruption of contractual relationships, which is not conducive to value capture.
    This study brings four academic contributions, including the introduction of the concept of IPDC, which extends the application of dynamic capabilities to IPR coopetition; the rich case studies of IPR coopetition strategies, which extends the field of coopetition research in relation to IPR coopetition research; the proposed concept of IPSO, which extends the scope of the application of real options in IPR strategies; and the discovery of the interaction between IPSO and IPSO, which enriches the empirical evidence of IPR strategies and the theory of organizational boundary definition. Finally, the study concludes with practical and future research recommendations.
    Reference: 書籍、專書論文、期刊、法院及相關報告
    Aghion, P., & Tirole, J. (1994). The management of innovation. The Quarterly Journal of Economics, 109(4), 1185-1209.
    Agostini, L., Caviggioli, F., Filippini, R., & Nosella, A. (2015). Does patenting influence SME sales performance? A quantity and quality analysis of patents in Northern Italy. European Journal of Innovation Management, 18(2), 238-257.
    Ahn, K., Trujillo, A., Gibbons, J., Bennett, C. L., & Anderson, G. (2023). Settled: Patent characteristics and litigation outcomes in the pharmaceutical industry. International Review of Law and Economics, 76, 106169.
    Al-Aali, A. Y., & Teece, D. J. (2013). Towards the (strategic) management of intellectual property: Retrospective and prospective. California Management Review, 55(4), 15-30.
    Aldiabat, K. M., & Le Navenec, C.-L. (2018). Data saturation: The mysterious step in grounded theory methodology. The Qualitative Report, 23(1), 245-261.
    Ali, A., & Gittelman, M. (2016). Research paradigms and useful inventions in medicine: Patents and licensing by teams of clinical and basic scientists in Academic Medical Centers. Research Policy, 45(8), 1499-1511.
    Allison, J. R., & Lemley, M. A. (1998). Empirical evidence on the validity of litigated patents. AIPLA Quarterly Journal, 26, 185-275.
    Ananthraman, S., Cambré, B., Kittler, M., & Delcamp, H. (2024). Divide and conquer: Relating patent quality and value in a conceptual framework based on a systematic review. International Journal of Management Reviews, 26, 285-311.
    Anderson, J., & Markides, C. (2007). Strategic innovation at the base of the pyramid. Mit Sloan Management Review, 49(1), 83-88.
    Andrews' Professional Liability Litigation Reporter, (February, 1998). TX biotech firm seeks relief from “unreasionable” attorneys’ fees, Tanox Biosystems Inc. v. Akin, Gump, Strauss, Hauer & Feld LLP et al., 7 No. 6 Anpllr 6.
    Ansari, S., Garud, R., & Kumaraswamy, A. (2016). The disruptor's dilemma: TiVo and the US television ecosystem. Strategic management journal, 37(9), 1829-1853.
    Anton, J. J., Greene, H. & Yao, D. A. (2006). Policy Implications of Weak Patent Rights. In Innovation Policy and the Economy, Volume 6, edited by Adam B. Jaffe, Josh Lerner, and Scott Stern, 1-26. Cambridge, Mass. and London: MIT Press.
    Antonelli, G. A., Leone, M. I., & Ricci, R. (2022). Exploring the Open COVID Pledge in the fight against COVID‐19: a semantic analysis of the Manifesto, the pledgors and the featured patents. R&D Management, 52(2), 255-272.
    Arora, A. (1997). Patents, licensing, and market structure in the chemical industry. Research Policy, 26(4-5), 391-403.
    Arora, A., & Fosfuri, A. (2003). Licensing the market for technology. Journal of Economic Behavior & Organization, 52(2), 277-295.
    Arora, A., Fosfuri, A., & Gambardella, A. (2004). Markets for Technology: The economics of Innovation and Corporate Strategy: Cambridge, MA: MIT press.
    Arrow, K. J. (1962). Economic welfare and the allocation of resources for invention. In R. Nelson (Ed.), The Rate and Direction of Inventive Activity: Economic and Social Factors, New York: Princeton University Press, 609-625.
    Arrow, K. J. (1984). Information and economic behavior. In K. J. Arrow (Ed.), The Economics of Information. Cambridge, MA: Belknap Press of Harvard University Press.
    Ayres, I., & Klemperer, P. (1998). Limiting Patentee's Market Power Without Reducing Innovation Incentives: The Perverse Benefits of Uncertainty and Non-Injunctive Remedies. Michigan Law Review, 97(4), 985-1033.
    Bacon, E., Williams, M. D., & Davies, G. (2020). Coopetition in innovation ecosystems: A comparative analysis of knowledge transfer configurations. Journal of Business Research, 115, 307-316.
    Baker, S., & Mezzetti, C. (2005). Disclosure as a strategy in the patent race. The Journal of Law and Economics, 48(1), 173-194.
    Baum, J. A., & Korn, H. J. (1996). Competitive dynamics of interfirm rivalry. Academy of Management Journal, 39, 255-255.
    Bar, T., (2006). Defensive publications in an R&D race. Journal of Economics & Management Strategy, 15(1), 229-254.
    Bar-Gill, O., & Parchomovsky, G. (2003). The value of giving away secrets. Virginia Law Review, 89, 1857-1895.
    Bar-Gill, O., & Parchomovsky, G. (2009). Law and the boundaries of technology-intensive firms. University of Pennsylvania Law Review, 157, 1649-1689.
    Barney, J. B. (1986). Strategic factor markets: Expectations, luck, and business strategy. Management Science, 32(10), 1231-1241.
    Barney, J. B. (1991). Firm resources and sustained competitive advantage. Journal of Management, 17(1), 99-120.
    Barrales-Molina, V., Gutierrez-Gutierrez, L., & Riquelme-Medina, M. (2023). International breadth in coopetition and innovation performance: evidence from the Spanish biotechnology industry. Industry and Innovation, 30(2), 286-309.
    Barrett, B. (2002). Defensive use of publications in an intellectual property strategy. Nature Biotechnology, 20(2), 191-193.
    Baumard, P. (2009). An asymmetric perspective on coopetitive strategies. International Journal of Entrepreneurship and Small Business, 8(1), 6-22.
    Bekkers, R., Duysters, G., & Verspagen, B. (2002). Intellectual property rights, strategic technology agreements and market structure: The case of GSM. Research Policy, 31(7), 1141-1161.
    Bengtsson, M., Eriksson, J., & Wincent, J. (2010). Co‐opetition dynamics–an outline for further inquiry. Competitiveness Review, 20(2), 194-214.
    Bengtsson, M., & Kock, S. (2000). “Coopetition” in business networks—to cooperate and compete simultaneously. Industrial Marketing Management, 29(5), 411-426.
    Bengtsson, M., & Kock, S. (2014). Coopetition—Quo vadis? Past accomplishments and future challenges. Industrial Marketing Management, 43(2), 180-188.
    Bengtsson, M., Kock, S., Lundgren-Henriksson, E.-L., & Näsholm, M. H. (2016a). Coopetition research in theory and practice: Growing new theoretical, empirical, and methodological domains. Industrial Marketing Management, 57, 4-11.
    Bengtsson, M., & Raza-Ullah, T. (2016). A systematic review of research on coopetition: Toward a multilevel understanding. Industrial Marketing Management, 57, 23-39.
    Bengtsson, M., Raza-Ullah, T., & Vanyushyn, V. (2016b). The coopetition paradox and tension: The moderating role of coopetition capability. Industrial Marketing Management, 53, 19-30.
    Bessen, J. E. & Nuvolari, A., (2012). Knowledge sharing among inventors: some historical perspectives. In: Harhoff, D., Lakhani, K. R. (Eds.), Revolutionizing Innovation: Users, Communities, and Open Innovation. MIT Press.
    Blind, K., Cremers, K., & Mueller, E. (2009). The influence of strategic patenting on companies’ patent portfolios. Research Policy, 38(2), 428-436.
    Blumer, H. (1969). Symbolic Interactionism: Perspective and Method. Englewood Cliffs, NJ: Prentice-Hall.
    Bogers, M. (2011). The open innovation paradox: knowledge sharing and protection in R&D collaborations. European Journal of Innovation Management, 14(1), 93-117.
    Bone, R. G. (1998). A new look at trade secret law: Doctrine in search of justification. California Law Review, 86(2), 241-313.
    Bouncken, R. B., & Fredrich, V. (2016). Learning in coopetition: Alliance orientation, network size, and firm types. Journal of Business Research, 69(5), 1753-1758.
    Bouncken, R. B., Fredrich, V., Kraus, S., & Ritala, P. (2020a). Innovation alliances: balancing value creation dynamics, competitive intensity and market overlap. Journal of Business Research, 112, 240-247.
    Bouncken, R. B., Fredrich, V., Ritala, P., & Kraus, S. (2018). Coopetition in new product development alliances: advantages and tensions for incremental and radical innovation. British Journal of Management, 29(3), 391-410.
    Bouncken, R. B., Fredrich, V., Ritala, P., & Kraus, S. (2020b). Value-creation-capture-equilibrium in new product development alliances: a matter of coopetition, expert power, and alliance importance. Industrial Marketing Management, 90, 648-662.
    Bouncken, R. B., Gast, J., Kraus, S., & Bogers, M. (2015). Coopetition: a systematic review, synthesis, and future research directions. Review of Managerial Science, 9, 577-601.
    Bouncken, R. B., & Kraus, S. (2013). Innovation in knowledge-intensive industries: The double-edged sword of coopetition. Journal of Business Research, 66(10), 2060-2070.
    Brandenburger, A. M., & Nalebuff, B. J. (1996). Co-opetition. New York: Doubleday.
    Brandenburger, A., & Nalebuff, B. (2021). The Rules of Co-opetition. Harvard Business Review, 99(1), 48-57.
    Brandenburger, A. M., & Nalebuff, B. J. (1995). The right game: Use game theory to shape strategy: Harvard Business Review, Chicago.
    Burk, D. L., & McDonnell, B. H. (2007). The Goldilocks hypothesis: Balancing intellectual property rights at the boundary of the firm. University of Illinois Law Review, 2007(2), 575-636.
    Cao, Y., Ren, S., & Du, M. (2022). Strategic trademark management: a systematic literature review and prospects for future research. Journal of Brand Management, 29(5), 435-453.
    Cassiman, B., Di Guardo, M. C., & Valentini, G. (2009). Organising R&D projects to profit from innovation: Insights from co-opetition. Long Range Planning, 42(2), 216-233.
    Charmaz, K. (2014). Constructing Grounded Theory (2nd ed ed.). London, UK: Sage Publications.
    Chen, M. J. (1996). Competitor analysis and interfirm rivalry: Toward a theoretical integration. Academy of Management Review, 21(1), 100-134.
    Chen, M. J. (2008). Reconceptualizing the competition—cooperation relationship: A transparadox perspective. Journal of Management Inquiry, 17(4), 288-304.
    Chen, M. J., & Miller, D. J. (2012). Competitive dynamics: Themes, trends, and a prospective research platform. Academy of Management Annals, 6(1), 135-210.
    Chen, M. J., & Miller, D. (2015). Reconceptualizing competitive dynamics: A multidimensional framework. Strategic Management Journal, 36(5), 758-775.
    Chenitz, W. C. (1986). Getting started: The research proposal for a grounded theory study. In W. Chenitz, & J. Swanson (Eds.), From Practice to Grounded Theory: Qualitative Research in Nursing, Menlo Park, CA: Addison-Wesley, 39-47.
    Chesbrough, H. (2003). Open Innovation: The New Imperative for Creating and Profiting from Technology. USA: Harvard Business School.
    Chesbrough, H. (2019). Open coopetition. In A.-S. Fernandez, P. Chiambaretto, F. L. Roy, & W. Czakon (Eds.), Routledge Companion to Coopetition Strategies. New York: Routledge.
    Chevallier, C., Laarraf, Z., Lacam, J. S., Miloudi, A., & Salvetat, D. (2016). Competitive intelligence, knowledge management and coopetition: The case of European high-technology firms. Business Process Management Journal, 22(6), 1192-1211.
    Chiambaretto, P., & Fernandez, A.-S. (2016). The evolution of coopetitive and collaborative alliances in an alliance portfolio: The Air France case. Industrial Marketing Management, 57, 75-85.
    Chiambaretto, P., Massé, D., & Mirc, N. (2019). “All for one and one for all?”-Knowledge broker roles in managing tensions of internal coopetition: The Ubisoft case. Research Policy, 48(3), 584-600.
    Chien, C. V. (2014). Holding up and holding out. Michigan Telecommunications & Technology Law Review, 21(1), 1-41.
    Chim-Miki, A. F., & Batista-Canino, R. M. (2017). The coopetition perspective applied to tourism destinations: A literature review. Anatolia, 28(3), 381-393.
    Coase, R. H. (1937). The Nature of the Firm. Economica, 4(16), 386-405.
    Cohen, W. M., & Levinthal, D. A. (1990). Absorptive capacity: A new perspective on learning and innovation. Administrative Science Quarterly, 35(1), 128-152.
    Conley, J. G., Bican, P. M., & Ernst, H. (2013). Value articulation: a framework for the strategic management of intellectual property. California Management Review, 55(4), 102-120.
    Conti, R., Gambardella, A., & Novelli, E. (2013). Research on markets for inventions and implications for R&D allocation strategies. Academy of Management Annals, 7(1), 717-774.
    Contreras, J. L., Eisen, M., Ganz, A., Lemley, M., Molloy, J., Peters, D. M., & Tietze, F. (2020). Pledging intellectual property for COVID-19. Nature Biotechnology, 38(10), 1146-1149.
    Corbo, L., Kraus, S., Vlačić, B., Dabić, M., Caputo, A., & Pellegrini, M. M. (2023). Coopetition and innovation: A review and research agenda. Technovation, 122, 102624.
    Corne, J., Djukanovic, R., Thomas, L., Warner, J., Botta, L., Grandordy, B., Gygax, D., Heusser, C., Patalano, F., & Richardson, W. (1997). The effect of intravenous administration of a chimeric anti-IgE antibody on serum IgE levels in atopic subjects: efficacy, safety, and pharmacokinetics. The Journal of Clinical Investigation, 99(5), 879-887.
    Cozzolino, A., Corbo, L., & Aversa, P. (2021). Digital platform-based ecosystems: The evolution of collaboration and competition between incumbent producers and entrant platforms. Journal of Business Research, 126, 385-400.
    Cozzolino, A., & Rothaermel, F. T. (2018). Discontinuities, competition, and cooperation: Coopetitive dynamics between incumbents and entrants. Strategic Management Journal, 39(12), 3053-3085.
    Crick, J. M. (2020). The dark side of coopetition: when collaborating with competitors is harmful for company performance. Journal of Business & Industrial Marketing, 35(2), 318-337.
    Crick, J. M. (2021). Unpacking the relationship between a coopetition-oriented mindset and coopetition-oriented behaviours. Journal of Business & Industrial Marketing, 36(3), 400-419.
    Crick, J. M., & Crick, D. (2020). Coopetition and COVID-19: Collaborative business-to-business marketing strategies in a pandemic crisis. Industrial Marketing Management, 88, 206-213.
    Cuypers, I. R. P., Hennart, J.-F., Silverman, B. S., & Ertug, G. (2021). Transaction Cost Theory: Past Progress, Current Challenges, and Suggestions for the Future. Academy of Management Annals, 15(1), 111-150.
    Cygler, J., Sroka, W., Solesvik, M., & Dębkowska, K. (2018). Benefits and drawbacks of coopetition: The roles of scope and durability in coopetitive relationships. Sustainability, 10(8), 2688.
    Czakon, W., & Czernek, K. (2016). The role of trust-building mechanisms in entering into network coopetition: The case of tourism networks in Poland. Industrial Marketing Management, 57, 64-74.
    Czakon, W., Gnyawali, D., Le Roy, F., & Srivastava, M. K. (2020a). Coopetition strategies: Critical issues and research directions. Long Range Planning, 53(1), 101948.
    Czakon, W., Mucha-Kuś, K., & Rogalski, M. (2014). Coopetition research landscape-a systematic literature review 1997-2010. Journal of Economics and Management, 17, 122-150.
    Czakon, W., Niemand, T., Gast, J., Kraus, S., & Frühstück, L. (2020b). Designing coopetition for radical innovation: An experimental study of managers' preferences for developing self-driving electric cars. Technological Forecasting and Social Change, 155, 119992.
    D’Agostino, L. M., & Schiavo, S. (2024). Using trademarks to fend off import competition: Evidence from the top R&D-spending companies. International Business Review, 33(1), 102206.
    Dahl, J., Kock, S., & Lundgren-Henriksson, E.-L. (2016). Conceptualizing coopetition strategy as practice: A multilevel interpretative framework. International Studies of Management & Organization, 46(2-3), 94-109.
    de Bettignies, J.-E., Liu, H. F., Robinson, D. T., & Gainullin, B. (2023). Competition and innovation in markets for technology. Management Science, 69(8), 4753-4773.
    De Rassenfosse, G., Jensen, P. H., Julius, T. M., Palangkaraya, A., & Webster, E. (2023). Is the patent system an even playing field? The effect of patent attorney firms. The Journal of Industrial Economics, 71(1), 124-142
    Den Uijl, S., Bekkers, R., & de Vries, H. J. (2013). Managing intellectual property using patent pools: Lessons from three generations of pools in the optical disc industry. California Management Review, 55(4), 31-50.
    Department of Justice. (1995). Antitrust guidelines for the licensing of intellectual property: US Department of Justice, Federal Trade Commission.
    Department of Justice. (2017). Antitrust guidelines for the licensing of intellectual property: US Department of Justice and Federal Trade Commission.
    Devece, C., Ribeiro-Soriano, D. E., & Palacios-Marqués, D. (2019). Coopetition as the new trend in inter-firm alliances: literature review and research patterns. Review of Managerial Science, 13, 207-226.
    Diestre, L., Lumineau, F., & Durand, R. (2023). Litigate or let it go? Multi-market contact and IP infringement-litigation dynamics. Research Policy, 52(6), 104784.
    Dillon, T. A., Lee, R. K., & Matheson, D. (2005). Value innovation: Passport to wealth creation. Research-Technology Management, 48(2), 22-36.
    Dorn, S., Schweiger, B., & Albers, S. (2016). Levels, phases and themes of coopetition: A systematic literature review and research agenda. European Management Journal, 34(5), 484-500.
    Dosi, G. (1982). Technological paradigms and technological trajectories: a suggested interpretation of the determinants and directions of technical change. Research Policy, 11(3), 147-162.
    Druedahl, L. C., Minssen, T., & Price, W. N. (2021). Collaboration in times of crisis: A study on COVID-19 vaccine R&D partnerships. Vaccine, 39(42), 6291-6295.
    Dubois, A., & Gadde, L.-E. (2002). Systematic combining: an abductive approach to case research. Journal of Business Research, 55(7), 553-560.
    Dyer, J. H., Singh, H., & Hesterly, W. S. (2018). The relational view revisited: A dynamic perspective on value creation and value capture. Strategic Management Journal, 39(12), 3140-3162.
    Dyer, J. H., & Singh, H. J. A. (1998). The relational view: Cooperative strategy and sources of interorganizational competitive advantage. Academy of Management Review, 23(4), 660-679.
    Dyer, W. G., & Wilkins, A. L. (1991). Better stories, not better constructs, to generate better theory: A rejoinder to Eisenhardt. Academy of Management Review, 16(3), 613-619.
    Efrat, K., Souchon, A. L., Wald, A., Hughes, P., & Cai, J. (2022). Mitigating coopetition tensions: The forgotten formation stage. European Management Review, 19(4), 527-548.
    Ehrnsperger, J. F., & Tietze, F. (2019). Patent pledges, open IP, or patent pools? Developing taxonomies in the thicket of terminologies. PLoS One, 14(8), e0221411.
    Eisenhardt, K., & Martin, J. (2000). Dynamic capabilities: What are they? Strategic Management Journal, 21(10/11), 1105-1121.
    Eisenhardt, K. M. (1989). Building theories from case study research. Academy of Management Review, 14(4), 532-550.
    Eisenhardt, K. M., & Graebner, M. E. (2007). Theory building from cases: Opportunities and challenges. Academy of Management Journal, 50(1), 25-32.
    Epstein, R. A., Kieff, F. S., & Spulber, D. F. (2012). The FTC, IP, and SSOs: Government hold-pp replacing private coordination. Journal of Competition Law & Economics, 8(1), 1-46.
    Epstein, R. A. & Noroozi, K. B. (2017). Why Incentives for “patent holdout” threaten to dismantle FRAND, and why it matters. Berkeley Technology Law Journal, 32(4), 1381-1432.
    Ernst, H., Kahle, H. N., Dubiel, A., Prabhu, J., & Subramaniam, M. (2015). The antecedents and consequences of affordable value innovations for emerging markets. Journal of Product Innovation Management, 32(1), 65-79.
    Ertekin, L., Sorescu, A., & Houston, M. B. (2018). Hands off my brand! The financial consequences of protecting brands through trademark infringement lawsuits. Journal of Marketing, 82(5), 45-65.
    Ertug, G., Brennecke, J., & Tasselli, S. (2023). Theorizing about the implications of multiplexity: An integrative typology. Academy of Management Annals, 17(2), 626–654.
    ESP Wiki, (2013). IBM v. TurboHercules in 2010, Retrieved January 19, 2023, from: https://wiki.endsoftwarepatents.org/wiki/IBM_v._TurboHercules_in_2010
    Estrada, I. (2018). Knowledge management in coopetition, The Routledge Companion to Coopetition Strategies, Routledge Abingdon, UK, 167-178.
    Estrada, I., Faems, D., & de Faria, P. (2016). Coopetition and product innovation performance: The role of internal knowledge sharing mechanisms and formal knowledge protection mechanisms. Industrial Marketing Management, 53, 56-65.
    Fagerberg, J. (2005). Innovation: A guide to the literature. In J. Fagerberg, Mowery, D. C., & Nelson, R. R. (Ed.), The Oxford Handbook of Innovation. USA: The Oxford University Press.
    Fang, S.-R., Chang, Y.-S., & Peng, Y.-C. (2011). Dark side of relationships: A tensions-based view. Industrial Marketing Management, 40(5), 774-784.
    Feldman, M. J., (1994). Toward a clearer standard of protectable information: Trade secrets and the employment relationship. High Technology Law Journal, 9(1), 151-183.
    Felin, T., Foss, N. J., Heimeriks, K. H., & Madsen, T. L. (2012). Microfoundations of routines and capabilities: Individuals, processes, and structure. Journal of Management Studies, 49(8), 1351-1374.
    Fernandez, A.-S., & Chiambaretto, P. (2016). Managing tensions related to information in coopetition. Industrial Marketing Management, 53, 66-76.
    Fisher, W. W., & Oberholzer-Gee, F. (2013). Strategic management of intellectual property: an integrated approach. California Management Review, 55(4), 157-183.
    Flick, U. (2022). An Introduction to Qualitative Research (7th Ed.). London: Sage Publication.
    Foege, J. N., Lauritzen, G. D., Tietze, F., & Salge, T. O. (2019). Reconceptualizing the paradox of openness: How solvers navigate sharing-protecting tensions in crowdsourcing. Research Policy, 48(6), 1323-1339.
    Fosfuri, A. (2006). The licensing dilemma: understanding the determinants of the rate of technology licensing. Strategic Management Journal, 27(12), 1141-1158.
    Fredrich, V., Bouncken, R. B., & Kraus, S. J. J. (2019). The race is on: Configurations of absorptive capacity, interdependence and slack resources for interorganizational learning in coopetition alliances. Journal of Business Research, 101, 862-868.
    Gast, J., Gundolf, K., Harms, R., & Collado, E. M. (2019). Knowledge management and coopetition: how do cooperating competitors balance the needs to share and protect their knowledge?. Industrial Marketing Management, 77, 65-74.
    Gelei, A., & Dobos, I. J. R. (2023). Micro-coopetition: conceptualizing and operationalizing coopetitive managerial decision-making over time—A game theoretic approach. Review of Managerial Science, 1-25.
    Gernsheimer, O., Kanbach, D. K., & Gast, J. (2021). Coopetition research-A systematic literature review on recent accomplishments and trajectories. Industrial Marketing Management, 96, 113-134.
    Gibbert, M., Ruigrok, W., & Wicki, B. (2008). What passes as a rigorous case study? Strategic Management Journal, 29(13), 1465-1474.
    Gioia, D. A., & Chittipeddi, K. (1991). Sensemaking and sensegiving in strategic change initiation. Strategic Management Journal, 12(6), 433-448.
    Gioia, D. A., Corley, K. G., & Hamilton, A. L. (2013). Seeking qualitative rigor in inductive research: Notes on the Gioia methodology. Organizational Research Methods, 16(1), 15-31.
    Gnyawali, D. R., & Park, B.-J. R. (2011). Co-opetition between giants: Collaboration with competitors for technological innovation. Research Policy, 40(5), 650-663.
    Gnyawali, D. R., & Park, B. J. (2009). Co‐opetition and technological innovation in small and medium‐sized enterprises: A multilevel conceptual model. Journal of Small Business Management, 47(3), 308-330.
    Gnyawali, D. R., & Ryan-Charleton, T. (2018). Nuances in the interplay of competition and cooperation: Towards a theory of coopetition, Journal of Management, 44(7), 2511-2534.
    Goffin, K., Åhlström, P., Bianchi, M., & Richtnér, A. (2019). Perspective: State‐of‐the‐art: The quality of case study research in innovation management. Journal of Product Innovation Management, 36(5), 586-615.
    Goldberg, V. P. (1976). Regulation and administered contracts. The Bell Journal of Economics, 7(2), 426-448.
    Grant, R., & Phene, A. (2022). The knowledge based view and global strategy: Past impact and future potential. Global Strategy Journal, 12(1), 3-30.
    Granstrand, O. (1999). The Economics and Management of Intellectual Property：towards intellectual capitalism, Cheltenham, UK: Edward Elgar Publishing.
    Granstrand, O., & Holgersson, M. (2015). Intellectual Property. In D. T. Cook, & J. M. Ryan (Eds.), The Wiley Blackwell Encyclopedia of Consumption and Consumer Studies. US: Wiley-Blackwell.
    Grant, R. M. (1996). Toward a knowledge‐based theory of the firm. Strategic Management Journal, 17(S2), 109-122.
    Grimaldi, M., Greco, M., & Cricelli, L. (2021). A framework of intellectual property protection strategies and open innovation. Journal of Business Research, 123, 156-164.
    Gruner, R. L., & Minunno, R. (2023). Theorizing across boundaries: How to conduct a ‘breakout’literature review. International Journal of Management Reviews, 1-3.
    Guntern, P., & Eggel, A. (2020). Past, present, and future of anti‐IgE biologics. Allergy, 75(10), 2491-2502.
    Hajar, M. A., Alkahtani, A. A., Ibrahim, D. N., Darun, M. R., Al-Sharafi, M. A., & Tiong, S. K. (2021). The approach of value innovation towards superior performance, competitive advantage, and sustainable growth: A systematic literature review. Sustainability, 13(18), 10131.
    Hall, B., Helmers, C., Rogers, M., & Sena, V. (2014). The Choice between Formal and Informal Intellectual Property: A Review. Journal of Economic Literature, 52(2), 375-423.
    Hamel, G. (1991). Competition for competence and interpartner learning within international strategic alliances. Strategic Management Journal, 12(S1), 83-103.
    Hamel, G. (1998). Opinion: Strategy innovation and the quest for value. Sloan Management Review, 39(2), 7-14.
    Hamilton, D. P. (2005). How Genentech, Novartis stifled a promising drug; Biotech firm tried to pursue peanut allergy injection, but contract got in way; Zach avoids a" kiss of death". The Wall Street Journal, 1-10.
    Hani, M., & Dagnino, G. B. (2021). Global network coopetition, firm innovation and value creation. Journal of Business & Industrial Marketing, 36(11), 1962-1974.
    Hanisch, M., Graf‐Vlachy, L., Haeussler, C., König, A., & Cho, T. S. (2024). Kindred spirits: Cognitive frame similarity and good faith provisions in strategic alliance contracts. Strategic Management Journal, 1-31.
    Hannah, D., Parent, M., Pitt, L., & Berthon, P. (2019). Secrets and knowledge management strategy: the role of secrecy appropriation mechanisms in realizing value from firm innovations. Journal of Knowledge Management, 23(2), 297-312.
    Hargadon, A. B., & Douglas, Y. (2001). When innovations meet institutions: Edison and the design of the electric light. Administrative Science Quarterly, 46(3), 476-501.
    Hart, O. (2009). Hold-up, asset ownership, and reference points. The Quarterly Journal of Economics, 124(1), 267-300.
    Kawakami, T. (2018). Kimishige Ishizaka 1925–2018. Nature Immunology, 19(9), 900-900.
    Heiden, B., & Petit, N. (2018). Patent “trespass” and the royalty gap: Exploring the nature and impact of patent holdout. Santa Clara High Technology Law Journal, 34(2), 179-249.
    Heikkilä, J. T., & Peltoniemi, M. (2023). The changing work of IPR attorneys: 30 years of institutional transitions. Technological Forecasting and Social Change, 197, 122853.
    Henkel, J., & Pangerl, S. (2008). Defensive publishing: An empirical study. DRUID Working Paper No. 08-0, 1-34.
    Higham, K., de Rassenfosse, G., & Jaffe, A. B. (2021). Patent Quality: Towards a Systematic Framework for Analysis and Measurement. Research Policy, 50(4), 1-26.
    Hill, C. W. L, Hwang, L. P. & Kim, W. C., (1990). An eclectic theory of the choice of international entry mode. Strategic Management Journal, 11(2), 117-128.
    Ho, H., & Ganesan, S. (2013). Does knowledge base compatibility help or hurt knowledge sharing between suppliers in coopetition? The role of customer participation. Journal of Marketing, 77(6), 91-107.
    Hoffmann, W., Lavie, D., Reuer, J. J., & Shipilov, A. (2018). The interplay of competition and cooperation. Strategic Management Journal, 39(12), 3033-3052.
    Holgersson, M., & Granstrand, O. (2022). Value capture in open innovation markets: the role of patent rights for innovation appropriation. European Journal of Innovation Management, 25(6), 320-339.
    Holgersson, M., Granstrand, O., & Bogers, M. (2018). The evolution of intellectual property strategy in innovation ecosystems: Uncovering complementary and substitute appropriability regimes. Long Range Planning, 51(2), 303-319.
    Hora, W., Gast, J., Kailer, N., Rey-Marti, A., & Mas-Tur, A. (2018). David and Goliath: causes and effects of coopetition between start-ups and corporates. Review of Managerial Science, 12, 411-439.
    Hrdy, C. A. (2022). The value in secrecy. Fordham Law Review, 91, 557-607.
    Hurmelinna-Laukkanen, P., & Yang, J. (2022). Distinguishing between appropriability and appropriation: A systematic review and a renewed conceptual framing. Research Policy, 51(1), 104417.
    Johnson, J. P. (2014). Defensive publishing by a leading firm. Information Economics and Policy, 28, 15-27.
    Jung, S. H., & Kouvelis, P. (2022). On co-opetitive supply partnerships with end-product rivals: Information asymmetry, dual sourcing and supply market efficiency. Manufacturing & Service Operations Management, 24(2), 1040-1055.
    Kale, P., Singh, H., & Perlmutter, H. (2000). Learning and protection of proprietary assets in strategic alliances: Building relational capital. Strategic Management Journal, 21(3), 217-237.
    Kang, H. & Lee, W. (2022). How innovating firms manage knowledge leakage: A natural experiment on the threat of worker departure. Strategic Management Journal, 43, 1961-1982.
    Kim, W. C., & Mauborgne, R. (1997). Value innovation: The strategic logic of high growth. Harvard Business Review, 75(1), 103-112.
    Kim, W. C., & Mauborgne, R. (1999). Strategy, value innovation, and the knowledge economy. MIT Sloan Management Review, Spring, 41-54.
    Kim, W. C., & Mauborgne, R. (2005). Blue ocean strategy: from theory to practice. California Management Review, 47(3), 105-121.
    Kim, Y. A. (2020). A critical appraisal of IBM’s patent pledge model: the impact of patent quality on open source software START-UP’s market entry decision. World Patent Information, 62, 101987.
    Klammer, A., Hora, W., & Kailer, N. (2023). Opposites attract: How incumbents learn and unlearn in coopetitive relationships with start-ups. Industrial Marketing Management, 112, 85-97.
    Kogut, B., & Zander, U. (1992). Knowledge of the firm, combinative capabilities, and the replication of technology. Organization Science, 3(3), 383-397.
    Kwon, S., & Marco, A. C. (2021). Can antitrust law enforcement spur innovation? Antitrust regulation of patent consolidation and its impact on follow-on innovations. Research Policy, 50(9), 104295.
    Kylänen, M., & Rusko, R. (2011). Unintentional coopetition in the service industries: The case of Pyhä-Luosto tourism destination in the Finnish Lapland. European Management Journal, 29(3), 193-205.
    Lado, A. A., Boyd, N. G., & Hanlon, S. C. (1997). Competition, cooperation, and the search for economic rents: A syncretic model. Academy of Management Review, 22(1), 110-141.
    Landes, W. M. & Posner, R. A. (2003). The Economic Structure of Intellectual Property Law. Belknap Press.
    Langlois, J., BenMahmoud-Jouini, S., & Servajean-Hilst, R. (2023). Practicing secrecy in open innovation – The case of a military firm. Research Policy, 52(1), 104626.
    Lanjouw, J. O., & Schankerman, M. (2001). Characteristics of patent litigation: a window on competition. RAND Journal of Economics, 32(1), 129-151.
    Lascaux, A. (2020). Coopetition and trust: What we know, where to go next. Industrial Marketing Management, 84, 2-18.
    Laursen, K., & Salter, A. J. (2014). The paradox of openness: Appropriability, external search and collaboration. Research Policy, 43(5), 867-878.
    Lavie, D. (2007). Alliance portfolios and firm performance: A study of value creation and appropriation in the US software industry. Strategic Management Journal, 28(12), 1187-1212.
    Lemley, M. A., & Shapiro, C. (2007). Patent Holdup and Royalty Stacking. Texas Law Review, 85, 1991-2049.
    Le Roy, F., & Chesbrough, H. (2018). Open coopetition. In A.-S. Fernandez, P. Chiambaretto, F. L. Roy, & W. Czakon (Eds.), Routledge Companion to Coopetition Strategies, New York: Routledge, 398-408.
    Le Roy, F., & Czakon, W. (2016). Managing coopetition: the missing link between strategy and performance. Industrial Marketing Management, 53(1), 3-6.
    Le Roy, F., Robert, F., & Hamouti, R. (2022). Vertical vs horizontal coopetition and the market performance of product innovation: An empirical study of the video game industry. Technovation, 112, 102411.
    Lee, Y., Fong, E. A., & Kim, H. (2023). Coopetition and technology licensing partner selection. Industrial Marketing Management, 112, 60-70.
    Leiponen, A., & Byma, J. (2009). If you cannot block, you better run: Small firms, cooperative innovation, and appropriation strategies. Research Policy, 38(9), 1478-1488.
    Lemley, M. A., & Shapiro, C. (2005). Probabilistic patents. Journal of Economic Perspectives, 19(2), 75-98.
    Lemley, M. A., & Shapiro, C. (2007). Patent holdup and royalty stacking. Texas Law Review, 85, 1991-2049.
    Lemley, M. A. & Shapiro, C. (2013). A Simple Approach to Setting Reasonable Royalties for Standard-Essential Patents, Berkeley Technology Law Journal, 28, 1135-1149.
    Letcher, B., de Villiers Scheepers, M., & Graham, W. (2022). Small firm coopetition–the missing links: coopetitive tension, balance and value. Journal of Business & Industrial Marketing, 37(11), 2247-2259.
    Levin, R. C., Klevorick, A. K., Nelson, R. R., Winter, S. G., Gilbert, R., & Griliches, Z. (1987). Appropriating the returns from industrial research and development. Brookings Papers on Economic Activity, 18(3), 783-831.
    Lewis, M. W., & Smith, W. K. (2022). Reflections on the 2021 AMR Decade Award: Navigating paradox is paradoxical. Academy of Management Review, 47(4), 528-548.
    Li, B. C. (2016). The global convergence of FRAND licensing practices: Towards "interoperable" legal standards. Berkeley Technology Law Journal 31, 429-432.
    Liebeskind, J. P. (2009). Knowledge, strategy, and the theory of the firm. In J. P. Liebeskind (Eds), Knowledge and Strategy, Routledge, 197-219.
    Llobet, G., & Padilla, J. (2023). A theory of socially inefficient patent holdout. The Journal of Economics & Management Strategy, 32(2), 424-449.
    Love, B. J., & Helmers, C. (2023). Patent hold-out and licensing frictions: Evidence from litigation of standard essential patents. International Journal of Industrial Organization, 89, 102978.
    Luo, Y. (2007). A coopetition perspective of global competition. Journal of world business, 42(2), 129-144.
    Markides, C. (1997). Strategic innovation. Sloan Management Review, 38(3), 9-23.
    Markovic, S., Jovanovic, M., Bagherzadeh, M., Sancha, C., Sarafinovska, M., & Qiu, Y. (2020). Priorities when selecting business partners for service innovation: The contingency role of product innovation. Industrial Marketing Management, 88, 378-388.
    Matthyssens, P., Vandenbempt, K., & Berghman, L. (2006). Value innovation in business markets: Breaking the industry recipe. Industrial Marketing Management, 35(6), 751-761.
    Mattioli, M. (2018). Patent pool outsiders. Berkeley Technology Law Journal, 33(1), 233-296.
    Meena, A., Dhir, S., & Sushil, S. (2023). A review of coopetition and future research agenda. Journal of Business & Industrial Marketing, 38(1), 118-136.
    Meschnig, A., & Dubiel, A. (2023). From formation to performance outcomes: A review and agenda for licensing research. Journal of Business Research, 167, 114181.
    Miles, M. B., & Huberman, A. M. (1994). Qualitative Data Analysis: An Expanded Sourcebook. Thousand Oaks, CA: Sage Publications.
    Nahapiet, J., & Ghoshal, S. (1998). Social capital, intellectual capital, and the organizational advantage. Academy of Management Review, 23(2), 242-266.
    Nason, R. S., & Wiklund, J. (2018). An assessment of resource-based theorizing on firm growth and suggestions for the future. Journal of Management, 44(1), 32-60.
    Nemeh, A., Yami, S. J. R., & Management, D. (2019). Orchestrating resources for FMA in coopetitive NPD. R&D Management, 49(1), 64-85.
    Nenonen, S., Storbacka, K., & Windahl, C. (2019). Capabilities for market-shaping: triggering and facilitating increased value creation. Journal of the Academy of Marketing Science, 47, 617-639.
    Niesten, E., & Stefan, I. (2019). Embracing the paradox of interorganizational value co‐creation–value capture: A literature review towards paradox resolution. International Journal of Management Reviews, 21(2), 231-255.
    Nieto, M. J., & Santamaría, L. (2007). The importance of diverse collaborative networks for the novelty of product innovation. Technovation, 27(6-7), 367-377.
    O’Donnell, C. (2015). Patented Creativity: Reflecting on Video Game Patents. In Garo P. Green, & James C. Kaufman (Eds), Video Games and Creativity, Chapter 12: Elsevier, 247-261.
    O’reilly, C. A., & Tushman, M. L. (2008). Ambidexterity as a dynamic capability: Resolving the innovator's dilemma. Research in Organizational Behavior, 28, 185-206.
    Oliver, C. (1991). Strategic responses to institutional processes. Academy of Management Review, 16(1), 145-179.
    Ozcan, O., Pickernell, D., & Trott, P. (2023). A Trade Secrets Framework and Strategic Approaches. IEEE Transactions on Engineering Management, 1-17.
    Racine‐Poon, A., Botta, L., Chang, T. W., Davis, F. M., Gygax, D., Liou, R. S., Rohane, P., Staehelin, T., van Steijn, A. M., & Frank, W. (1997). Efficacy, pharmacodynamics, and pharmacokinetics of CGP 51901, an anti‐immunoglobulin E chimeric monoclonal antibody, in patients with seasonal allergic rhinitis. Clinical Pharmacology & Therapeutics, 62(6), 675-690.
    Park, B.-J. R., Srivastava, M. K., & Gnyawali, D. R. (2014). Walking the tight rope of coopetition: Impact of competition and cooperation intensities and balance on firm innovation performance. Industrial Marketing Management, 43(2), 210-221.
    Pellegrin-Boucher, E., Le Roy, F., & Gurău, C. (2013). Coopetitive strategies in the ICT sector: typology and stability. Technology Analysis & Strategic Management, 25(1), 71-89.
    Peng, T. J. A., Yen, M. H., & Bourne, M. (2018). How rival partners compete based on cooperation? Long Range Planning, 51(2), 351-383.
    Penrose, E. T. (1959). The Theory of the Growth of the Firm. New York: John Wiley.
    Pettigrew, A. M. (1990). Longitudinal field research on change: Theory and practice. Organization Science, 1(3), 267-292.
    Pfeffer, J. (1982). Organizations and Organization Theory. MA: Pitman: Marshfield.
    Phillips, A. (2023). The Safe Harbor of 35 USC § 271 (e)(1): The costly confusion about the scope of "patented invention". Indiana Health Law Review, 20(1), 143-172.
    Pitt, M., & Clarke, K. (1999). Competing on competence: A knowledge perspective on the management of strategic innovation. Technology Analysis & Strategic Management, 11(3), 301-316.
    Pundziene, A., Gutmann, T., Schlichtner, M., & Teece, D. J. (2022). Value impedance and dynamic capabilities: the case of MedTech Incumbent-Born digital healthcare platforms. California Management Review, 64(4), 108-134.
    Raza-Ullah, T., Bengtsson, M., & Kock, S. (2014). The coopetition paradox and tension in coopetition at multiple levels. Industrial Marketing Management, 43(2), 189-198.
    Raza-Ullah, T., & Kostis, A. (2020). Do trust and distrust in coopetition matter to performance?, European Management Journal, 38(3), 367-376.
    Reitzig, M., & Wagner, S. (2010). The hidden costs of outsourcing: Evidence from patent data. Strategic Management Journal, 31(11), 1183-1201.
    Ritala, P., Golnam, A., & Wegmann, A. (2014). Coopetition-based business models: The case of Amazon. com. Industrial Marketing Management, 43(2), 236-249.
    Ritala, P., & Hurmelinna-Laukkanen, P. (2009). What's in it for me? Creating and appropriating value in innovation-related coopetition. Technovation, 29(12), 819-828.
    Ritala, P., & Hurmelinna‐Laukkanen, P. (2013). Incremental and radical innovation in coopetition—The role of absorptive capacity and appropriability. Journal of Product Innovation Management, 30(1), 154-169.
    Ritala, P., Kraus, S., & Bouncken, R. B. (2016). Introduction to coopetition and innovation: contemporary topics and future research opportunities. International Journal of Technology Management, 71(1-2), 1-9.
    Ritala, P., & Stefan, I. (2021). A paradox within the paradox of openness: The knowledge leveraging conundrum in open innovation. Industrial Marketing Management, 93, 281-292.
    Rouyre, A., & Fernandez, A.-S. (2019). Managing knowledge sharing-protecting tensions in coupled innovation projects among several competitors. California Management Review, 62(1), 95-120.
    Rumelt, R. P. (1984). Toward a strategic theory of the firm. In R. Lamb (Ed.), Competitive Strategic Management, Englewood Cliffs, NJ: Prentice Hall, 556-570.
    Rumelt, R. P. (2011). Good Strategy/Bad Strategy: The Difference and Why it Matters. London: Profile Books.
    Runge, S., Schwens, C., & Schulz, M. J. S. M. J. (2022). The invention performance implications of coopetition: How technological, geographical, and product market overlaps shape learning and competitive tension in R&D alliances. Strategic Management Journal, 43, 266-294.
    Ryan-Charleton, T., Gnyawali, D. R., & Oliveira, N. (2022). Strategic alliance outcomes: Consolidation and new directions. Academy of Management Annals, 16(2), 719-758.
    Sanou, F. H., Le Roy, F., & Gnyawali, D. R. (2016). How does centrality in coopetition networks matter? An empirical investigation in the mobile telephone industry. British Journal of Management, 27(1), 143-160.
    Santos, F. M., & Eisenhardt, K. M. (2005). Organizational boundaries and theories of organization. Organization Science, 16(5), 491-508.
    Schautschick, P., & Greenhalgh, C. (2016). Empirical studies of trade marks–the existing economic literature. Economics of Innovation and New Technology, 25(4), 358-390.
    Scott, W. R. (2013). Institutions and Organizations: Ideas, Interests, and Identities: Sage publications.
    Shapiro, C. (2003). Antitrust limits to patent settlements. RAND Journal of Economics, 34(2), 391-411.
    Shaver, L. (2012). Illuminating innovation: From patent racing to patent war. Washington and Lee Law Review, 69, 1891-1947.
    Sherry, E. F., & Teece, D. J. (2004). Royalties, evolving patent rights, and the value of innovation. Research Policy, 33(2), 179-191.
    Shijaku, E., & Ritala, P. (2023). Behavioral antecedents of firm's ego-network competitiveness: The case of the global pharmaceuticals. Long Range Planning, 56(3), 102308.
    Smith, K. G., Grimm, C. M., & Gannon, M. J. (1992). Dynamics of Competitive Strategy. Newbury Park, CA: Sage Publications.
    Smith, W. K., & Lewis, M. W. (2011). Toward a theory of paradox: A dynamic equilibrium model of organizing. Academy of Management Review, 36(2), 381-403.
    Somaya, D. (2012). Patent strategy and management: An integrative review and research agenda. Journal of Management, 38(4), 1084-1114.
    Somaya, D., Teece, D., & Wakeman, S. (2011). Innovation in multi-invention contexts: Mapping solutions to technological and intellectual property complexity. California Management Review, 53(4), 47-79.
    Song, J., Lee, K., & Khanna, T. (2016). Dynamic capabilities at Samsung: Optimizing internal co-opetition. California Management Review, 58(4), 118-140.
    Southern District of New York. (1921). Bayer Co., Inc. v. United Drug Co., 272 F. 505.
    Sull, D. N. (2005). Why good companies go bad. Financial Times, 3, 1-6.
    Sung, H.-C. (2023). A critical review of current trends in licensing standard essential patents from the perspectives of patent law and supply chain management. Journal of the Patent and Trademark Office Society, 103, 431-463.
    Supreme Court Division of General Court of Justice, (July 6, 2021). Synpac Venture Capital, L.P and CSRC International Investment Holdings Co., LTD., Plaintiffs, v. Duke University, Defendant. NO. 21-CVS-2647.
    Tanox. (2001b). Court Stays Lawsuit Against Tanox, Inc.; Judge Returns Parties to Arbitration.
    Teece, D. J. (1986). Profiting from technological innovation: Implications for integration, collaboration, licensing and public policy. Research Policy, 15(6), 285-305.
    Teece, D. J. (1988). Technological change and the nature of the firm. In Technological Change and Economic Theory, Dosi G, Freeman C, Nelson R, Silverberg G, Soete L (Eds). London: Pinter, 256-281.
    Teece, D. J. (2006). Reflections on “profiting from innovation”. Research Policy, 35(8), 1131-1146.
    Teece, D. J. (2007). Explicating dynamic capabilities: the nature and microfoundations of (sustainable) enterprise performance. Strategic Management Journal, 28(13), 1319-1350.
    Teece, D. J. (2010). Business models, business strategy and innovation. Long Range Planning, 43(2-3), 172-194.
    Teece, D. J. (2014). The foundations of enterprise performance: Dynamic and ordinary capabilities in an (economic) theory of firms. Academy of Management perspectives, 28(4), 328-352.
    Teece, D. J. (2015). Intangible assets and a theory of heterogeneous firms. In A. Bounfour, & T. Miyagawa (Eds.), Intangibles, Market Failure and Innovation Performance, New York: Springer, 217-239.
    Teece, D. J. (2016). Dynamic capabilities and entrepreneurial management in large organizations: Toward a theory of the (entrepreneurial) firm. European Economic Review, 86, 202-216.
    Teece, D. J. (2017). The tragedy of the anticommons fallacy: a law and economics analysis of patent thickets and FRAND licensing. Berkeley Technology Law Journal, 32, 1489.
    Teece, D. J. (2018a). Dynamic capabilities as (workable) management systems theory. Journal of Management & Organization, 24(3), 359-368.
    Teece, D. J. (2018b). Profiting from innovation in the digital economy: Enabling technologies, standards, and licensing models in the wireless world. Research Policy, 47(8), 1367-1387.
    Teece, D. J. (2019). Coopetition and the dynamic capabilities framework. In A.-S. Fernandez, P. Chiambaretto, F. L. Roy, & W. Czakon (Eds.), Routledge Companion to Coopetition Strategies, New York: Routledge, 349-357.
    Teece, D. J. (2020). Fundamental issues in strategy: Time to reassess? Strategic Management Review, 1(1), 103-144.
    Teece, D. J. (2021). Technological leadership and 5G patent portfolios: Guiding strategic policy and licensing decisions. California Management Review, 63(3), 5-34.
    Teece, D. J., Pisano, G., & Shuen, A. (1997). Dynamic capabilities and strategic management. Strategic Management Journal, 18(7), 509-533.
    Teece, D. J., Pundziene, A., Heaton, S., & Vadi, M. (2022). Managing Multi-Sided Platforms: Platform Origins and Go-to-Market Strategy. California Management Review, 64(4), 5-19.
    Teixeira, J., Mian, S., & Hytti, U. (2016). Cooperation among competitors in the open-source arena: The case of OpenStack. Research working paper, Cornell University, arXiv preprint arXiv:1612.09462, 1-38.
    Telg, N., Lokshin, B., & Letterie, W. (2023). How formal and informal intellectual property protection matters for firms' decision to engage in coopetition: The role of environmental dynamism and competition intensity. Technovation, 124, 102751.
    Tidström, A., & Rajala, A. (2016). Coopetition strategy as interrelated praxis and practices on multiple levels. Industrial Marketing Management, 58, 35-44.
    Tidström, A., & Hagberg-Andersson, Å. (2012). Critical events in time and space when cooperation turns into competition in business relationships. Industrial Marketing Management, 41(2), 333-343.
    Torres de Oliveira, R., Verreynne, M.-L., Steen, J., & Indulska, M. (2021). Creating value by giving away: A typology of different innovation revealing strategies. Journal of Business Research, 127, 137-150.
    Trigeorgis, L., Baldi, F., & Makadok, R. (2022). Compete, cooperate, or both? Integrating the demand side into patent deployment strategies for the commercialization and licensing of technology. Academy of Management Review, 47(1), 31-58.
    Tucker, R. B. (2001). Strategy innovation takes imagination. Journal of Business Strategy, 22(3), 23-23.
    United States District Court, District of Delaware, (April 3, 2024). Arbutus biopharma corporation and Genevant sciencess GmbH, Plaintiffs, v. Moderna, Inc. and ModernaTX, Inc., Memorandum Opinion, No. 22-252.
    United States District Court for the Northern District of California, (December 19, 2003). Taiwan Semiconductor Manufacturing Company, Ltd., Plaintiff, v. Semiconductor Manufacturing International Corporation; Semiconductor Manufacturing International (Shanghai) Company, Ltd.; and SMIC Americas, Defendants. No. 3:03-cv-05761.
    United States District Court for the Northern District of California, (February 15, 2018a). Defendant United Microelectronics Corporation’s notice of motion and motion to dismiss for lack of personal jurisdiction, No. 4:17-CV-6932-JSW.
    United States District Court for the Southern District of New York, (April 15, 2008a). Keryx Biopharmaceuticals, Inc. v. Panion & BF Biotech, Inc., No. 1:08-cv-03603-DLC.
    United States District Court for the Southern District of New York, (July 4, 2008b). Defendant’s answer and counterclaims. Keryx Biopharmaceuticals, Inc. v. Panion & BF Biotech, Inc., No. 1:08-cv-03603-DLC.
    United States District Court for the Southern District of Texas, (1994a). Tanox Biosystems, Inc. v. Genentech, Inc. et al., No. H-94-0189.
    United States District Court for the Southern District of Texas, (1994b). Genentech, Inc. v. Tanox Biosystems, Inc., No. H-94-0239.
    United States District Court for the Southern District of Texas, (March 21, 1995a). Tanox's answer to Genentech's amended complaint. Genentech v. Tanox Biosystems and Ciba-Geigy, No. H-94-0189.
    United States District Court for the Southern District of Texas, (July 13, 1995b). Defendant Ciba-Geigy Limited's answer and counterclaim to the amended complaint. Genentech v. Tanox Biosystems and Ciba-Geigy, No. H-94-0189.
    United States District Court of Massachusetts, (August 29, 2007a). iRobot Corporation v. Jameel Ahed and Robotic FX, Inc., 1:07-cv-11611.
    United States Texas Eastern District Court, (September 12, 2022). Daedalus Prime LLC v. Taiwan Semiconductor Manufacturing Co Ltd, Samsung Electronics Co Ltd and Samsung Electronics America Inc. No. 2:22-cv-00352.
    United States Texas Eastern District Court, (June 22, 2023). Daedalus Prime LLC v. Taiwan Semiconductor Manufacturing Co Ltd. No. 2:23-cv-00299.
    U.S. District Court for the Western District of Washington, (June 18, 2007a). Microsoft Corporation v. Immersion Corporation. No. 2:07-CV-00936.
    U.S. District Court for the Western District of Washington, (June 25, 2007b). Microsoft Corporation v. Immersion Corporation. First amended complaint for breach of contract. No. CV7-936RSM.
    U.S. District Court Northern District of California, (2002). Immersion Corporation v. Sony Computer Entertainment of America, Inc., Sony Computer Entertainment Inc., and Microsoft Corporation, Case No. C02-00710 CW (WDB).
    U.S. District Court Northern District of California, (March 24, 2005). Order entering permanent injunction and granting defendants’ motion to stay injunction pending appeal. Immersion Corporation v. Sony Computer Entertainment America, Inc. No. C 02-0710 CW.
    U.S. District Court Northern District of California, (March 8, 2006). Order denying defendants’ motion for relief from final judgement. Immersion Corporation v. Sony Computer Entertainment America, Inc. No. C 02-0710 CW.
    U.S. International Trade Commission (ITC), (September 13, 2017a). Joint status report for the first settlement conference between complainant iRobot and respondents Bissell and Matsutek, Document Id: 622906, 337-1057, Investigation No. 337-1057.
    U.S. International Trade Commission (ITC), (November 16, 2017c). Joint status report for the second settlement conference between complainant iRobot and respondents Bissell and Matsutek, Document Id: 629034, Investigation No. 337-1057.
    U.S. International Trade Commission (ITC), (September 13, 2023). In the matter of certain semiconductor devices, mobile devices containing the same, and components thereof. No. 337-TA-1336.
    U.S. International Trade Commission (ITC), (November 14, 2023). In the matter of certain semiconductor devices, mobile devices containing the same, and components thereof. Initial determination granting joint motion to terminate the investigation due to settlement and denying as moot request to limit service of the settlement agreement. Order No. 78, No. 337-TA-1336.
    van der Duin, P., Trott, P., & Ortt, R. (2024). Failed technology management: Introducing ‘future technology myopia’and how to address it. Technological Forecasting and Social Change, 198, 122927.
    Velu, C. (2016). Evolutionary or revolutionary business model innovation through coopetition? The role of dominance in network markets. Industrial Marketing Management, 53, 124-135.
    von Hippel, E. (1988). The Sources of Innovation. NY: Oxford University Press.
    von Hippel, E. (2005). Democratizing Innovation. MIT Press, Cambridge, MA.
    Wang, J.-Y. (2013). What Taiwan contributes to the world of allergy and clinical immunology? Asia Pacific Allergy, 3(4), 209-214.
    Wang, Y., Zhang, X., Cheng, T., & Wu, T.-H. (2023). Choice of the co-opetition model for a new energy vehicle supply chain under government subsidies. Transportation Research Part E: Logistics and Transportation Review, 179, 103326.
    Wilden, R., Devinney, T. M., & Dowling, G. R. (2016). The architecture of dynamic capability research identifying the building blocks of a configurational approach. Academy of Management Annals, 10(1), 997-1076.
    Williamson, O. E. (1981). The economics of organization: The transaction cost approach. American Journal of Sociology, 87(3), 548-577.
    Williamson, O. E. (1991). Comparative economic organization: The analysis of discrete structural alternatives. In Sven-Erik Sjostrand (Ed.), Institutional Change: Theory and Empirical Findings, New York: Routledge, 269-296.
    Winter, S. G. (2003). Understanding dynamic capabilities. Strategic Management Journal, 24(10), 991-995.
    Wouters, O. J., McKee, M., & Luyten, J. (2020). Estimated research and development investment needed to bring a new medicine to market, 2009-2018. JAMA, 323(9), 844-853.
    Yami, S., & Nemeh, A. (2014). Organizing coopetition for innovation: The case of wireless telecommunication sector in Europe. Industrial Marketing Management, 43(2), 250-260.
    Yan, Y., Dong, J. Q., & Faems, D. (2020). Not every coopetitor is the same: The impact of technological, market and geographical overlap with coopetitors on firms’ breakthrough inventions. Long Range Planning, 53(1), 101873.
    Yang, Z. (2014). Damaging Royalties: An Overview of Reasonable Royalty Damages, Berkeley Technology Law Journal 29, 647-652.
    Yang, J., Chesbrough, H., & Hurmelinna-Laukkanen, P. (2022). How to appropriate value from general-purpose technology by applying open innovation. California Management Review, 64(3), 24-48.
    Yin, R. K. (2009). Case study research: Design and Methods (4th Ed.). Thousand Oaks, CA: Sage.
    Yin, R. K. (2012). Applications of Case Study Research. Thousand Oaks: SAGE.
    Yin, R. K. (2015). Qualitative Research from Start to Finish. Guilford publications.
    Yuan, X., & Li, X. (2022). Pledging patent rights for fighting against the COVID-19: from the ethical and efficiency perspective. Journal of Business Ethics, 179(3), 683-696.
    Zain, S. (2006). Suppression of innovation or collaborative efficiencies?: An antitrust analysis of a research & development collaboration that led to the shelving of a promising drug. John Marshall Review of Intellectual Property Law, 5, 348-381.
    Zhang, J., & Baden-Fuller, C. (2010). The influence of technological knowledge base and organizational structure on technology collaboration. Journal of Management Studies, 47(4), 679-704.
    Zheng, W., Tu, H., Gu, Y., & Sun, H. (2023). The “human side” of coopetition: the role of CEO mindsets in firm coopetition for innovation. Asia Pacific Journal of Management, 1-29.
    Zhu, F., & Iansiti, M. (2012). Entry into platform‐based markets. Strategic Management Journal, 33(1), 88-106.
    Zulu-Chisanga, S., Oghazi, P., Hultman, M., Leonidou, C. N., & Boso, N. (2023). Developing and utilizing coopetitive relationships: Evidence from small and medium-sized enterprises in sub-Saharan Africa. Journal of Business Research, 166, 114111.
    Zuckerman, G. (2022)。疫苗商戰：新冠危機下AZ、BNT、輝瑞、莫德納、嬌生、Novavax的生死競賽（廖月娟 、 張玄竺 、 鍾榕芳 、 黃瑜安 譯）。遠見天下文化出版股份有限公司。（原著出版於2021年）。
    王仁君與張永宏，(2018)。淺論營業秘密之保護及證據保全。全國律師，
    第22卷第10期，頁28-40。
    文永順，(2024b年7月26日)，【新藥製研 布局國際】劑型開發的藥廠授權新實踐，【2024臺北市生技產業高峰論壇】決戰國際未來舞台 臺灣生醫海外進行式，台北：南港展覽館。
    王偉霖，(2024)。營業秘密法理論與實務。四版。台北：元照。
    吳東哲，(2021)。美國Actavis案後逆向給付協議之發展。公平交易季刊，第29卷第4期，頁83-122。
    李宗洲，(2013)，小資本開發新藥全球上市。啟動生技密碼二部曲，民視文化，台北市，頁：140-151。
    李孟珊，(2020年10月31日)，晉華案與美司法部和解 法務長剖析幕後決策—聯電組豪華律師團 致勝關鍵，經濟日報，A2版，投資大勢。
    李孟珊，(2022年4月15日)，車用業務 打入一線大廠，經濟日報，焦點A5。
    忻凌偉，(2014)，藥物晶型對生物利用度和生體相等性的影響，生物醫學，第7卷第1期，頁45-49。
    張小玫，(2018)。以專利共享經濟探討科技競合關係。台北：財團法人國家實驗研究院科技政策研究與資訊中心。
    黃郁涵，(2019)，P4學名藥的上市攻防戰—以美時戒毒癮學名藥為例，貨幣觀測與信用評等，第139期，頁104-111。
    最高法院104年度台上字第2016號判決。
    最高法院107年台上字第755號民事判決。
    智慧財產法院107年度民營上字第1號民事判決。
    智慧財產法院107年度民專上更(一)字第3號民事判決。
    慶辰法律事務所，(2022年7月29日)，「生技公司如何邁上成功之道？估值與授權有所不知」簡報，「2022亞洲生技大會」(2022 BIO Asia-Taiwan )。
    謝英哲、張元杰、王健航及李孟哲，(2018)，龐貝氏症的新藥開發：中國合成橡膠公司的管理實踐，中山管理評論，第26卷第4期，頁719-744。
    蕭瑞麟，(2020)。不用數字的研究：質性研究的思辯脈絡。5版，台北：五南。
    蘇友珊與吳豐祥，(2015)，台灣生技公司如何運用開放式創新開發新藥？，中山管理評論，第23卷，第1期，頁335-376。

    網際網路
    Adetunji, J. (November 30, 2023). Buvidal: is it really a ‘game changer’ in the treatment of problematic opioid use?. The Conversation, Retrieved April 30, 2024, from: https://theconversation.com/buvidal-is-it-really-a-game-changer-in-the-treatment-of-problematic-opioid-use-214895
    Akebia, (March 4, 2015). 2014 Annual report, Retrieved July 2, 2024, from: https://ir.akebia.com/static-files/971f42b3-dbe9-4480-b306-9a80552e1254
    All Prior Art, Retrieved December 26, 2022, from: https://allpriorart.com/about/
    Alosh, T. (October 20, 2020). Allele v. Regeneron & Allele v. Pfizer and BioNTech: The cases of a protein, a patent, and a pandemic. JOLT Digest, Retrieved Janauray 12, 2024, from: https://jolt.law.harvard.edu/digest/allele-v-regeneron-allele-v-pfizer-and-biontech-the-cases-of-a-protein-a-patent-and-a-pandemic
    Arbutus, (February 22 2018). Arbutus settles litigation, terminating Acuitas’ rights to LNP technology. Form 8-K. SEC, Retrieved March 4, 2024, from: https://arbutusbio.gcs-web.com/node/14136/html
    AstraZeneca, (2019). 2018 Annual report, Retrieved June 30, 2024, from: https://www.astrazeneca.com/content/dam/az/Investor_Relations/annual-report-2018/PDF/AstraZeneca_AR_2018.pdf
    Bauman, V. (June 5, 2020). Pharma collaborations in the Covid-19 era come with legal risks (1), Bloomberg Law, Retrieved Janauray 18, 2024, from: https://news.bloomberglaw.com/pharma-and-life-sciences/pharma-collaborations-in-the-covid-19-era-come-with-legal-risks
    BioMarin, (January 29, 2003). BioMarin, Genzyme receive FDA complete response letter on Aldurazyme. SEC, Retrieved June 19, 2024, from: https://www.sec.gov/Archives/edgar/data/1048477/000104847703000008/exhibit99012903.htm
    BioMarin, (November 6, 2008). Data to be presented at 58th annual meeting of the American Society of Human Genetics, Retrieved June 22, 2024, from: https://investors.BioMarin.com/news/news-details/2008/Data-to-Be-Presented-at-58th-Annual-Meeting-of-The-American-Society-of-Human-Genetics-11-06-2008/default.aspx
    BioMarin, (April 30, 2009). BioMarin announces first quarter 2009 financial results, Retrieved June 22, 2024, from: https://investors.BioMarin.com/news/news-details/2009/BioMarin-Announces-First-Quarter-2009-Financial-Results-04-30-2009/default.aspx
    BioMarin, (August 17, 2010). BioMarin acquires ZyStor Therapeutics, Inc, Retrieved June 19, 2024, from: https://investors.BioMarin.com/news/news-details/2010/BioMarin-Acquires-ZyStor-Therapeutics-Inc.-08-17-2010/default.aspx
    BioMarin, (February 24, 2011). 2010 Annual report, Retrieved June 19, 2024, from: https://d18rn0p25nwr6d.cloudfront.net/CIK-0001048477/3e3806e3-c168-4b3c-ab0f-029153452297.pdf
    BioMarin, (March 19, 2013). BioMarin to advance BMN-701 for Pompe disease to next phase of development, Retrieved June 21, 2024, from: https://www.apjohnventures.com/documents/BMRN_News_2013_3_19_General_Releases.pdf
    BioMarin & Genzyme, (January 3, 2008). BioMarin and Genzyme restructure Aldurazyme 50/50 joint venture. SEC, Retrieved June 19, 2024, from: https://www.sec.gov/Archives/edgar/data/732485/000110465908000688/a08-1296_1ex99d1.htm
    BioWorld, (January 24, 1994). Genentech and Tanox sue each other, Retrieved March 26, 2024, from: https://www.bioworld.com/articles/490443
    BioWorld, (November 16, 1994). Tanox signs $13m agreement with Takara Shuzo to develop kidney, Retrieved March 27, 2024, from: https://www.bioworld.com/articles/488858
    Boehringer Ingelheim, (2019). 2018 Annual report, Retrieved June 30, 2024, from: https://www.annualreports.com/HostedData/AnnualReportArchive/b/boehringer-ingelheim_2018.pdf
    Braeburn, (May 23, 2023). Braeburn’s BRIXADI™ (buprenorphine) extended-release subcutaneous injection (CIII) receives FDA approval for moderate to severe Opioid use disorder, Retrieved April 30, 2024, from: https://braeburnrx.com/braeburns-brixadi-buprenorphine-extended-release-subcutaneous-injection-ciii-receives-fda-approval-for-moderate-to-severe-opioid-use-disorder/
    Brittain, B. (January 22, 2022). Pfizer, biotech firm end patent fight over COVID-19 vaccine, REUTERS, Retrieved Janauray 12, 2024, from: https://www.reuters.com/legal/government/pfizer-biotech-firm-end-patent-fight-over-covid-19-vaccine-2022-01-05/
    Bultman, M. (2022). Allele, Pfizer call truce in patent dispute over Covid-19 vaccine: Bloomberg Law, Retrieved Janauray 10, 2024, from: https://news.bloomberglaw.com/ip-law/allele-pfizer-call-truce-in-patent-dispute-over-covid-19-vaccine
    Calboli, I. (2014). Trademarking creative works: trends and negative effects on the copyright equilibrium. In: Frankel, S. & Gervais, D. (Eds.), The Evolution and Equilibrium of Copyright in the Digital Age, series number 26, Cambridge University Press, Retrieved December 30, 2022, from: https://papers.ssrn.com/sol3/papers.cfm?abstract_id=2329569
    Camurus, (2024), Retrieved April 30, 2024, from: https://www.camurus.com/science/products/
    Canalys, (October 18, 2022). Global smartphone market fell 9% as consumers trim spending, Retrieved December 12, 2022, from: https://www.canalys.com/newsroom/global-smartphone-market-Q3-2022
    Center for Drug Evaluation and Research, (2019). Determining whether to submit an ANDA or a 505(b)(2) application guidance for industry. Food and Drug Administration, U.S. Department of Health and Human Services, Retrieved April 30, 2024, from: https://www.fda.gov/media/124848/download
    Chung, E. (March 12, 2024). Global top 10 foundries Q4 revenue up 7.9%, annual total hits US$111.54 billion in 2023, says TrendForce. TrendForce, Retrieved May 4, 2024, from: https://www.trendforce.com/presscenter/news/20240312-12072.html
    Counterpoint, (August 24, 2022). Global smartphone market share: By quarter, Retrieved December 12, 2022, from: https://www.counterpointresearch.com/global-smartphone-share/
    Court of Appeals of Texas, Houston (14th Dist.). (April 24, 2003). Tanox, Inc. v. Akin, Gump, Strauss, Hauer & Feld, L.L.P., 105 S.W.3d 244, 270. No. 14–00–00765–CV, Retrieved March 8, 2024, from: https://law.justia.com/cases/texas/fourteenth-court-of-appeals/2003/78176.html
    Deloitte, (2024). Unleash AI’s potential measuring the return from pharmaceutical innovation – 14th edition, Retrieved July 16, 2024, from：https://www2.deloitte.com/content/dam/Deloitte/us/Documents/life-sciences-health-care/us-rd-roi-14th-edition.pdf
    District Court for the Eastern District of Texas, (September 25, 2019). Largan Precision Co., Ltd. v. Ability Opto-Electronics Technology Co., Ltd.; Newmax Technology Co., Ltd.; and HP Inc., Defendants. No. 4:19-cv-00696, Retrieved May 23, 2024, from: https://insight.rpxcorp.com/litigation_documents/13508429
    Dunbar, E. D., & Landmon, C. A. (2021). IP and collaboration, pharmaceutical executive, 41(3), Retrieved August 3, 2023, from: https://www.pharmexec.com/view/ip-and-collaboration
    Dunleavy, K. (Mar 17, 2022). Alnylam sues Pfizer and Moderna claiming infringement on its delivery technology for COVID shots. FIERCE Pharma, Retrieved June 10, 2022, from: https://www.fiercepharma.com/pharma/alnylam-files-lawsuits-vs-pfizer-moderna-claiming-infringement-its-delivery-technology-covid
    Dunleavy, K. (December 17, 2023). Roche's Xolair moves step closer to FDA food allergy approval. FIERCE Pharma, Retrieved January 17, 2024, from: https://www.fiercepharma.com/pharma/roche-novartis-move-xolair-closer-fda-finish-line-food-allergies
    Edwards, J., & Quinn, G. (2020). Facilitating innovation to fight coronavirus act— Legislation that’s a mixed bag: IPWatchdog, Retrieved August 4, 2023, from: https://ipwatchdog.com/2020/04/08/facilitating-innovation-to-fight-coronavirus-act-legislation-mixed-bag/id=120483/
    Electronic Arts, (August 24, 2021). Our patent pledge for increasing accessibility, Retrieved January 16, 2023, from: https://www.ea.com/commitments/positive-play/accessibility-patent-pledge
    EUROGAMER, (2006). Comments for "PS3 could have rumble - Immersion president", Retrieved June 17, 2024, from: https://www.eurogamer.net/news190506ps3rumble?view=comments
    FDA, (May 24, 2010). Drug approval package—Lumizyme, Retrieved June 19, 2024, from: https://www.accessdata.fda.gov/drugsatfda_docs/nda/2010/125291s000TOC.cfm
    FDA, (August 6, 2021). FDA approves new treatment for Pompe disease, Retrieved June 20, 2024, from: https://www.fda.gov/news-events/press-announcements/fda-approves-new-treatment-pompe-disease
    FDA (U.S. Food & Drug Administration), (May 23, 2023). FDA approves new buprenorphine treatment option for Opioid use disorder, Retrieved April 30, 2024, from: https://www.fda.gov/news-events/press-announcements/fda-approves-new-buprenorphine-treatment-option-opioid-use-disorder
    FDA, (February 16, 2024). FDA approves first medication to help reduce allergic reactions to multiple foods after accidental exposure. FDA news release, Retrieved March 14, 2024, from: https://www.fda.gov/news-events/press-announcements/fda-approves-first-medication-help-reduce-allergic-reactions-multiple-foods-after-accidental
    Felbab-Brown, V. (March 21, 2024). China, Mexico, and America’s fight against the fentanyl epidemic. Brookings, Retrieved April 29, 2024, from: https://www.brookings.edu/articles/china-mexico-and-americas-fight-against-the-fentanyl-epidemic/
    Ford, (2024), What is global brand protection?. Global brand protection, Retrieved January 1, 2024, from: https://www.fordbrandprotection.com/
    Genentech, (February 28, 1997). 1996 Annual report, Retrieved June 27, 2024, from: https://www.gene.com/download/pdf/1996_annual-report.pdf
    Genentech and Tanox, (November 9, 2006). Genentech announces agreement to acquire Tanox for $20 per share. EX-99.1 2 dex991.htm press release issued jointly by Genentech, Inc. and Tanox Inc. SEC, Retrieved March 13, 2024, from: https://www.sec.gov/Archives/edgar/data/318771/000119312506237338/dex991.htm
    Genentech, Tanox, and Ciba-Geigy, (1996). Settlement and cross-licensing agreement, Retrieved March 27, 2024, from: https://contracts.onecle.com/tanox/genentech.settle-lic.1996.07.08.shtml
    General Court of the European Union, (June 19, 2019). The General Court of the EU confirms the invalidity of the adidas EU trade mark which consists of three parallel stripes applied in any direction. adidas AG v EUIPO, T-307/17, Retrieved March 4, 2024, from: https://curia.europa.eu/jcms/upload/docs/application/pdf/2019-06/cp190076en.pdf
    Genzyme, (February 23, 1999). 1998 Annual report. SEC, Retrieved June 19, 2024, from: http://pdf.secdatabase.com/4/0000950135-99-001750.pdf
    Genzyme, (April 2, 2000). 2000 Annual report. SEC, Retrieved June 19, 2024, from: http://getfilings.com/o0000912057-01-506403.html
    Genzyme, (April 1, 2002). 2001 Annual report. SEC, Retrieved June 19, 2024, from: https://www.sec.gov/Archives/edgar/data/732485/000091205702012898/a2073695z10-k.htm
    Genzyme, (February 26, 2010). 2009 Annual report. SEC, Retrieved June 19, 2024, from: https://www.sec.gov/Archives/edgar/data/732485/000104746910001574/a2196427z10-k.htm
    Gibson, E. (May 9, 2006). Rumble dropped from PS3 pad—More details of new controller. Eurogamer, Retrieved June 16, 2024, from: https://www.eurogamer.net/news090506ps3controllernews
    Google, (2023). Open patent non-assertion pledge, Retrieved January 1, 2023, from: https://www.google.com/patents/opnpledge/pledge/
    Graboyes, J. S., Murray, K., Nowacki, K., Rai, A. K., Sybo, A. & Wasserman, M. F. (March 31, 2023). Patent small claims—Report to the United States Patent and Trademark Office, Office of the Chair, Administrative Conference of the United States, Retrieved October 22, 2023, from: https://www.acus.gov/sites/default/files/documents/ACUS%20Report%20on%20Patent%20Small%20Claims%202023.pdf
    Honaker, W. (March 31 2022). NIH’s fight for ownership of Moderna’s COVID-19 patent highlights hazards of business collaborations, Retrieved January 5, 2024, from: https://ipwatchdog.com/2022/03/31/nihs-fight-ownership-modernas-covid-19-patent-highlights-hazards-business-collaborations/id=148040/
    Hosanagar, K., Lodish, L. & Berman, R. (September 14, 2017). Why Amazon’s ‘1-click’ Ordering was a game changer, Retrieved January 2, 2023, from: https://knowledge.wharton.upenn.edu/article/amazons-1-click-goes-off-patent/
    IBM TurboHercules patent threat letter, (2010), Retrieved January 19, 2023, from: http://www.zoobab.com/ibm-turbohercules-patent-threat-letter
    Immersion, (March 28, 2002). 2001 Annual report, Retrieved June 17, 2024, from: https://www.annualreports.co.uk/Company/immersion
    Immersion, (March 28, 2003). 2002 Annual report, Retrieved June 16, 2024, from: https://www.annualreports.co.uk/Company/immersion
    Immersion, (2024). About us. Company Website, Retrieved June 16, 2024, from: https://www.immersion.com/about/
    Indivior, (October 11, 2023). Indivior enters an exclusive licensing agreement with Alar Pharmaceuticals, Retrieved July 3, 2024, from: https://www.indivior.com/en/media/press-releases/Indivior-Enters-an-Exclusive-Licensing-Agreement-with-Alar-Pharmaceuticals
    Indivior, (2024). Annual report and accounts 2023, Retrieved July 3, 2024, from: https://www.indivior.com/resources/dam/id/1329/Indivior%20Annual%20Report%20and%20Accounts%202023.pdf
    iRobot, (March 16, 2006). 2005 Annual report, Retrieved March 19, 2024, from: https://investor.irobot.com/static-files/19bc017d-e19c-483d-b47c-693bf4ed36d2
    iRobot, (November 5, 2007a). iRobot granted injunction in trade secrets lawsuit. Retrieved April 18, 2024, from: https://investor.irobot.com/news-releases/news-release-details/irobot-granted-injunction-trade-secrets-lawsuit
    iRobot, (December 18, 2007b). iRobot wins $286 million U.S. army contract, Retrieved April 18, 2024, from: https://investor.irobot.com/news-releases/news-release-details/irobot-wins-286-million-us-army-contract
    iRobot, (February 19, 2010). 2009 Annual report, Retrieved March 19, 2024, from: https://investor.irobot.com/static-files/4688af43-0561-4f11-9cbe-de0fc2063044
    iRobot, (July 1, 2013). iRobot files lawsuit for infringement of five patents in Germany, Retrieved April 19, 2024, from: https://investor.irobot.com/news-releases/news-release-details/irobot-files-lawsuit-infringement-five-patents-germany
    iRobot, (May 14, 2014). iRobot's preliminary injunctions against Shenzhen Silver Star affirmed on all counts, Retrieved April 19, 2024, from: https://investor.irobot.com/news-releases/news-release-details/irobots-preliminary-injunctions-against-shenzhen-silver-star
    iRobot, (September 14, 2017). iRobot announces agreement with Micro-Star International in patent dispute, Retrieved April 23, 2024, from: https://investor.irobot.com/news-releases/news-release-details/irobot-announces-agreement-micro-star-international-patent
    iRobot, (April 10, 2018). 2017 iRobot annual report, Retrieved April 21, 2024, from: https://investor.irobot.com/static-files/6030c504-564e-4978-809c-b920d2b72c35
    Judgment of the General Court, (2023). Competition – Agreements, decisions and concerted practices – Modafinil market – Decision finding an infringement of Article 101 TFEU – Patent dispute settlement agreement – Restriction of competition by object – Characterisation – Restriction of competition by effect – Conditions for exemption under Article 101(3) TFEU – Fines. Court of Justice of the European Union, Retrieved November 8, 2023, from: https://curia.europa.eu/jcms/jcms/Jo2_7033/en/
    Khanna, N., (2019). Patent quality: Does one size fit all? 4iP council. EIPIN Innovation Society, research paper, No. 19-02, Retrieved March 12, 2021, from: https://www.eipin-innovationsociety.org/wp-content/uploads/2019/06/Working-paper-Naina-Khanna.pdf
    Keisner, C. Andrew, Raffo, Julio D. & Wunsch-Vincent, Sacha A., (2015). Breakthrough technologies - robotics, innovation and intellectual property. World Intellectual Property Organization (WIPO) Economic Research Working Paper Series No. 30, Retrieved April 14, 2023, from: SSRN: https://ssrn.com/abstract=4434131 or http://dx.doi.org/10.2139/ssrn.4434131
    Kontos, S. J. (2021). Why Tesla’s open source patent strategy reinforces the importance of patenting. StartupNation, Retrieved January 15, 2023, from: https://startupnation.com/manage-your-business/teslas-open-source-patent-strategy/
    Liu, A. (2020). Pfizer-BioNTech, Regeneron sued for patent infringement with COVID-19 products, FIERCE Pharma, Retrieved January 6, 2024, from: https://www.fiercepharma.com/pharma/pfizer-biontech-regeneron-sued-for-infringement-allele-s-patent-their-covid-19-products
    Liu, A. (November 23, 2021). Sanofi coughs up $180M to settle Pompe disease royalty payment dispute. FIERCE Pharma, Retrieved January 6, 2024, from: https://www.fiercepharma.com/pharma/sanofi-coughs-up-180m-to-settle-pompe-disease-drug-royalty-payment-dispute
    LOT-Network, (2022). LOT network pricing, Retrieved January 2, 2023, from: https://lotnet.com/lot-network-pricing/
    Madsen, A. (June 27, 2016). BioMarin discontinues development of Pompe drug. Muscular Dystrophy Association, Retrieved June 21, 2024, from: https://strongly.mda.org/biomarin-discontinues-development-of-pompe-drug/#:~:text=BioMarin%20Pharmaceutical%20has%20announced%20that%20it%20is%20discontinuing,helps%20break%20down%20sugar%20stored%20in%20cells%20%28glycogen%29
    Masur, J. S., & Ouellette, L. L. (2023). Patent Law: Cases, Problems, and Materials (3rd Ed.), Retrieved January 18, 2024, from: https://papers.ssrn.com/sol3/papers.cfm?abstract_id=4488545
    Micron, (October 27, 2015). 2015 annual report, Retrieved August 10, 2024, from: https://investors.micron.com/static-files/007ae015-401b-4392-bdee-d034b1a83fdf
    Micron, (October 15, 2018). 2018 annual report, Retrieved June 15, 2024, from: https://investors.micron.com/static-files/01e4b7a0-1cdf-4019-9aa2-6db5e2a1b6f2
    Micron, (November 25, 2021a). Micron and UMC announce global settlement, Retrieved May 2, 2024, from: https://investors.micron.com/news-releases/news-release-details/micron-and-umc-announce-global-settlement
    Micron, (December 1, 2021b). Micron and UMC expand relationship to strengthen customer supply chains, Retrieved May 2, 2024, from: https://investors.micron.com/news-releases/news-release-details/micron-and-umc-expand-relationship-strengthen-customer-supply
    Micron, (January 18, 2024). 2023 annual report, Retrieved May 9, 2024, from: https://investors.micron.com/static-files/25afc2b7-1b51-4f33-9d3b-9d1620fafa30
    Microsoft, (September 17, 2001). Microsoft 2001 annual report, Retrieved May 29, 2024, from: https://msftar.azurewebsites.net/investor/reports/ar01/low/form_10-k/item1.htm
    Microsoft, (September 5, 2002). Microsoft 2002 annual report, Retrieved May 29, 2024, from: https://www.microsoft.com/investor/reports/ar02/downloads/default.htm
    Microsoft, (September 4, 2003). Microsoft 2003 annual report, Retrieved May 29, 2024, from: https://www.microsoft.com/investor/reports/ar03/alt/downloads.htm
    Microsoft, (August 24, 2004). Microsoft 2004 annual report, Retrieved June 17, 2024, from: https://www.microsoft.com/en-us/Investor/annual-reports.aspx
    Microsoft, (August 23, 2005). Microsoft 2005 annual report, Retrieved June 17, 2024, from: https://www.microsoft.com/en-us/Investor/annual-reports.aspx
    Microsoft, (May 16, 2019). Sony and Microsoft to explore strategic partnership. Microsoft News Center, Retrieved May 31, 2024, from: https://news.microsoft.com/2019/05/16/sony-and-microsoft-to-explore-strategic-partnership/
    Microsoft, (July 27, 2023). Microsoft 2023 annual report, Retrieved May 29, 2024, from: https://www.microsoft.com/investor/reports/ar23/download-center/
    Moderna, (October 8, 2020). Statement by Moderna on intellectual property matters during the COVID-19 pandemic, Retrieved December 31, 2022, from: https://assets.modernatx.com/m/173fa66f31675e4c/original/Statement-by-Moderna-on-Intellectual-Property-Matters-during-the-COVID-19-Pandemic.pdf
    MPEG LA, 2023. 1394, Retrieved April 23, 2023, from: https://www.mpegla.com/programs/1394-program/faq/
    Musk, E. (June 12, 2014). All our patent are belong to you, Retrieved December 31, 2022, from: https://www.tesla.com/blog/all-our-patent-are-belong-you
    NATION．CYMRU, (July 14, 2023). Welsh university carries out ‘game changer’ drug treatment research, Retrieved April 30, 2024, from: https://nation.cymru/news/welsh-university-carries-out-game-changer-drug-treatment-research/
    Novartis, (February 26, 2003). Novartis, Genentech and Tanox settle disputes surrounding Xolair and TNX-901, Retrieved March 13, 2024, from: https://hugin.info/134323/R/1011728/157451.pdf
    Novartis, (January 29, 2019). Annual report 2018, Retrieved June 30, 2024, from: https://www.novartis.com/sites/novartis_com/files/novartis-annual-report-2018-en.pdf
    Novartis, Genentech, & Tanox, (February 25, 2004). Tripartite cooperation agreement. SEC. EX-10.1 2 dex101.htm, Retrieved March 16, 2024, from: https://www.sec.gov/Archives/edgar/data/1099414/000119312504083427/dex101.htm
    Open COVID-19 Declaration, (2020), Retrieved January 12, 2023, from: https://www.gckyoto.com/covid19/
    Open Covid Pledge, (2020), Retrieved January 1, 2023, from: https://opencovidpledge.org/pledgor-licenses/
    Pagliarulo, N. (February 28, 2022). Moderna sued for allegedly infringing patents tied to COVID-19 vaccine, BioPharma Dive, Retrieved January 6, 2024, from: https://www.biopharmadive.com/news/moderna-arbutus-roivant-lawsuit-patents-lnp-vaccine/619502/
    Panion & BF Biotech & Kery, (2008a). Amended & restated license agreement. SEC, Retrieved July 3, 2024, from: https://www.sec.gov/Archives/edgar/data/1114220/000114420408027790/v113586_ex10-1.htm
    Panion & BF Biotech & Kery, (2008b). First amendment to amended & restated license agreement. SEC, Retrieved July 3, 2024, from: https://www.sec.gov/Archives/edgar/data/1114220/000114420409017660/v144562_ex10-16.htm
    Panion & BF Biotech & Akebia, (2019). Second amendment and restated license agreement, SEC, Retrieved July 2, 2024, from: https://www.sec.gov/Archives/edgar/data/1517022/000156459019030771/akba-ex101_250.htm
    Patent Trial and Appeal Board, (July 21, 2020a). Ability Opto-Electronics Technology Co., Ltd, Petitioner, v. Largan Precision Co., Ltd, Patent Owner, U.S. Patent No. 8,988,796, IPR2020-01339, United States Patent and Trademark Office, Retrieved May 24, 2024, from: https://ptacts.uspto.gov/ptacts/public-informations/petitions/1539582/download-documents?artifactId=FX4rXuL0_8NhUtL6czCmEhwJ5E5p04gvTfmAXJQS7D2KA4y_NXHPs7g
    Patent Trial and Appeal Board, (July 22, 2020b). Ability Opto-Electronics Technology Co., Ltd, Petitioner, v. Largan Precision Co., Patent Owner, U.S. Patent No. 8,395,691, IPR2020-01345, United States Patent and Trademark Office, Retrieved May 24, 2024, from: https://ptacts.uspto.gov/ptacts/public-informations/petitions/1539603/download-documents?artifactId=9av3ohqWIaiGfDT66rVkDa8vZkMnW-BChH3f-S0vD7JSSkBYjuS_4wo
    Patent Trial and Appeal Board, (August 28, 2020c). Ability Opto-Electronics Technology Co., Ltd, Petitioner, v. Largan Precision Co., Patent Owner, U.S. Patent No. 9,146,378, IPR2020-01545, United States Patent and Trademark Office, Retrieved May 24, 2024, from: https://ptacts.uspto.gov/ptacts/public-informations/petitions/1540823/download-documents?artifactId=czHzxjiL6eduHVUalIrXsQzrHJWa-XYtwetUHgi4QLGDA3OfCjOaOew
    Patent Trial and Appeal Board, (March 8, 2021). Ability Opto-Electronics Technology Co., Ltd, Petitioner, v. Largan Precision Co., Patent Owner, Joint Motion to Terminate Pursuant to 35 U.S.C. § 317 AND 37 C.F.R. §§ 42.5, 42.71(a), 42.72, and 42.74, IPR2020-01339, IPR2020-01345, IPR2020-01545, Retrieved May 24, 2024, from: https://ptacts.uspto.gov/ptacts/public-informations/petitions/1539603/download-documents?artifactId=bMT4M11OqYsZV0NXRqeJsG_ex0JiT4xPN_hUxN1-a-X2uSKgGebuy2E
    PitchBook, (2024). ZyStor Therapeutics overview, Retrieved June 22, 2024, from: https://pitchbook.com/profiles/company/41701-42#overview
    Pollack, A. (March 13, 2003). Wrangling may delay peanut allergy drug, Retrieved August 1, 2024, from: https://www.nytimes.com/2003/03/13/business/wrangling-may-delay-peanut-allergy-drug.html
    Pronschinske, M. (April 6, 2010). IBM breaks patent pledge; Breaches the OSS Community's trust, DZone, Retrieved December 31, 2022, from: https://dzone.com/articles/ibm-breaks-patent-pledge
    Questel Research Disclosure, (2022), Retrieved December 25, 2022, from: https://www.researchdisclosure.com/Step/FileUpload
    Rauwald, C., & Keith, N. (2020). VW, Ford forge ahead with technology sharing to save costs. Bloomberg, Retrieved August 3, 2023, from: https://www.bloomberg.com/news/articles/2020-05-14/vw-ford-forge-ahead-with-ev-technology-sharing-to-cut-costs#xj4y7vzkg
    Rees, V. (2020). Sanofi and GSK to collaborate on COVID-19 vaccine development, European pharmaceutical review, Retrieved August 3, 2023, from: https://www.europeanpharmaceuticalreview.com/news/116913/sanofi-and-gsk-to-collaborate-on-covid-19-vaccine-development/
    Remo, C. (August 27, 2008). Microsoft, Immersion settle 'force feedback' lawsuit. game developer, Retrieved May 31, 2024, from: https://www.gamedeveloper.com/game-platforms/microsoft-immersion-settle-force-feedback-lawsuit
    Ringes, M. (April 20, 2020). IBM offering free access to patent portfolio to combat COVID-19, Retrieved January 1, 2023, from: https://www.ibm.com/blogs/research/2020/04/ibm-patent-portfolio-access-combat-covid-19/
    Roche. (February 17, 2024). FDA approves Xolair as first and only medicine for children and adults with one or more food allergies, Retrieved March 8, 2024, from: https://www.roche.com/media/releases/med-cor-2024-02-16
    Rogan, J. (2020). Does Tesla’s open source patent philosophy mean they are free to use?. Venner Shipley, Retrieved January 15, 2023, from: https://www.vennershipley.co.uk/insights-events/does-teslas-open-source-patent-philosophy-mean-they-are-free-to-use/
    Roivant Sciences, (February 28, 2022). Genevant Sciences and Arbutus Biopharma file patent infringement lawsuit against Moderna, Retrieved June 10, 2022, from: https://investor.roivant.com/news-releases/news-release-details/genevant-sciences-and-arbutus-biopharma-file-patent-infringement
    Rutschman, A. S., & Barnes-Weise, J. (2021). The COVID-19 vaccine patent waiver: The wrong tool for the right goal. Bill of Health, Retrieved August 4, 2023, from: https://blog.petrieflom.law.harvard.edu/2021/05/05/covid-vaccine-patent-waiver/
    Sanders, K. (September 14, 2006). Sixaxis the new dual shock? What will Sony call the new motion-sensitive PS3 controller?. IGN, Retrieved June 17, 2024, from: https://www.ign.com/articles/2006/09/13/sixaxis-the-new-dual-shock
    Sanofi, (January 2, 2019). 2018 annual report, Retrieved June 21, 2024, from: https://www.sanofi.com/en/investors/reports-and-publications/financial-reports-and-regulated-information
    Sanofi, (January 23, 2020). 2019 annual report, Retrieved June 21, 2024, from: https://www.sanofi.com/en/investors/reports-and-publications/financial-reports-and-regulated-information
    SEC, (2004). Tripartite cooperation agreement—By and between Novartis Pharma AG, Genentech, INC. and Tanox, INC, Retrieved March 13, 2024, from: https://www.sec.gov/Archives/edgar/data/1099414/000119312504083427/dex101.htm
    SEC, (2008). Settlement agreement of Microsoft and Immersion, Retrieved May 29, 2024, from: https://www.sec.gov/Archives/edgar/data/1058811/000095013408019838/f50289exv10w45.htm
    SEC, (June 19, 2018). Sublicense agreement of Microsoft and Immersion, Retrieved May 29, 2024, from: https://www.sec.gov/files/18-04468-e.pdf
    Serebrov, M. (2020). Biopharma opts for collaboration, not patent pools. BioWorld, Clarivate, Retrieved August 3, 2023, from: https://www.bioworld.com/articles/496984-biopharma-opts-for-collaboration-not-patent-pools?v=preview
    Shimel, A., (April 8, 2010). IBM goes from the sublime to the ridiculous on patents and open source. Network world, Retrieved December 31, 2022, from: https://www.networkworld.com/article/2230376/ibm-goes-from-the-sublime-to-the-ridiculous-on-patents-and-open-source.html
    Shores, D. (November 11, 2020). Breaking down Moderna’sCOVID-19 patent pledge: Why did they do it? IPWatchdog, Retrieved January 15, 2023, from: https://ipwatchdog.com/2020/11/11/breaking-modernas-covid-19-patent-pledge/id=127224/
    Shores, D., (April 30, 2021). The mRNA patent and competitive landscape: Pioneers, litigation outlook and big pharma’s next moves (Part III). IPWatchdog, Retrieved June 6, 2022, from: https://www.ipwatchdog.com/2021/04/30/mrna-patent-competitive-landscape-pioneers-litigation-outlook-big-pharmas-next-moves-part-iii/id=132936/
    Shores, D., Haversack, D., & Storaska, A, J, (April 11, 2021). The mRNA IP and competitive landscape through one year of the COVID-19 pandemic (Part I). IPWatchdog, Retrieved June 6, 2022, from: https://www.ipwatchdog.com/2021/04/11/mrna-ip-competitive-landscape-one-year-covid-19-pandemic-part/id=132130/.
    Shores, D., Haversack, D., & Storaska, A, J, (April 21, 2021). The mRNA IP and competitive landscape: Translate BIO; Arcturus; eTheRNA and other startups; and LNP technology (Part II). IPWatchdog, Retrieved June 6, 2022, from: https://www.ipwatchdog.com/2021/04/21/mrna-ip-competitive-landscape-translate-bio-arcturus-etherna-startups-lnp-technology-part-ii/id=132287/
    Sony, (March 31, 2003). Annual report 2003, Retrieved June 17, 2024, from: https://www.sony.com/en/SonyInfo/IR/library/ar/Archive.html
    Sony, (March 31, 2004). Annual report 2004, Retrieved June 17, 2024, from: https://www.sony.com/en/SonyInfo/IR/library/ar/Archive.html
    Sony, (March 31, 2005). Annual report 2005, Retrieved June 17, 2024, from: https://www.sony.com/en/SonyInfo/IR/library/ar/Archive.html
    Sony, (March 31, 2006). Annual report 2006, Retrieved June 17, 2024, from: https://www.sony.com/en/SonyInfo/IR/library/ar/Archive.html
    Sony, (March 31, 2007). Annual report 2007, Retrieved June 17, 2024, from: https://www.sony.com/en/SonyInfo/IR/library/ar/Archive.html
    Sony, (March 31, 2008). Annual report 2008, Retrieved June 17, 2024, from: https://www.sony.com/en/SonyInfo/IR/library/ar/Archive.html
    Statista Research Department, (March 8, 2011). Global market share of game consoles from 2006 to 2010. Statista, Retrieved June 17, 2024, from: https://www.statista.com/statistics/272048/global-market-shares-of-game-consoles/
    Statista Research Department, (2024), Robotic vacuum cleaner market revenue worldwide from 2015 to 2025, Retrieved April 20, 2024, from: https://www.statista.com/statistics/1022991/worldwide-robotic-vacuum-cleaner-revenue/
    Supreme Court of The United States, (May 18, 2023). Amgen Inc. et al. v. Sanofi et al. No. 21–757, Retrieved January 1, 2024, from: https://www.supremecourt.gov/opinions/22pdf/21-757_k5g1.pdf
    Supreme Court of The United States, (April 5, 2021). Google LLC. v. Oracle America, Inc. No. 18–956, Retrieved January 20, 2024, from: https://www.supremecourt.gov/opinions/20pdf/18-956_d18f.pdf
    Supreme Court of The United States, (May 15, 2006). eBay Inc et al v MercExchange, LLC, 547, US 388, Retrieved April 9, 2024, from: https://supreme.justia.com/cases/federal/us/547/388/
    The General Court. (2022). Apple v EUIPO - Swatch (THINK DIFFERENT), Case T-26/21. ECLI:EU:T:2022:350, Retrieved March 4, 2024, from: https://curia.europa.eu/juris/liste.jsf?lgrec=fr&td=%3BALL&language=en&num=T-26/21&jur=T
    The General Court. (2019). adidas v EUIPO - Shoe Branding Europe, Case T-307/17. ECLI:EU:T:2019:427, Retrieved March 4, 2024, from: https://curia.europa.eu/juris/liste.jsf?num=T-307/17
    Takahashi, D., (August 24, 2021). EA’s patent pledge will give competitors free access to accessibility technology. GamesBeat, Retrieve January 12, 2023, from: https://venturebeat.com/games/eas-patent-pledge-will-give-competitors-free-access-to-accessibility-technology/
    Tanox. (2001a). 2000 annual report, Retrieved March 27, 2024, from: https://www.sec.gov/Archives/edgar/data/1099414/000089924301000814/0000899243-01-000814-0001.txt
    Tanox and Roche, (1996). Settlement and participation agreement, Retrieved March 27, 2024, from: https://contracts.onecle.com/tanox/hoffman-laroche.settle.1996.07.08.shtml
    Tanox and Ciba-Geigy, (June 10, 1996). Supplemental agreement- Tanox Biosystems Inc. and Ciba-Geigy Ltd., Retrieved March 17, 2024, from: https://contracts.onecle.com/tanox/ciba-geigy.supp.1996.06.10.shtml
    Tanox, (March 30, 2001a). 2000 annual report. SEC. Form 10-K, Retrieved March 14, 2024, from: https://www.sec.gov/Archives/edgar/data/1099414/000089924301000814/0000899243-01-000814-0001.txt
    Tanox, (December 17, 2001b), Court stays lawsuit against Tanox, Inc.; Judge returns parties to arbitration, Retrieved March 15, 2024, from: https://web.archive.org/web/20160821191249/http:/www.thefreelibrary.com/Court+Stays+Lawsuit+Against+Tanox%2c+Inc.%3b+Judge+Returns+Parties+to...-a080862592
    Terry, M., (May 9, 2022). Moderna urges court to dismiss ongoing vaccine patent issues. BioSpace, Retrieved June 8, 2022, from: https://www.biospace.com/article/moderna-still-tangled-in-vaccine-patent-issues-urges-court-to-dismiss/
    Thorpe, H. (April 1995). Drug war!, Texas Monthly, Retrieved March 26, 2024, from: https://www.texasmonthly.com/news-politics/drug-war/
    Topology, (November 29, 2017). TrendForce reports top 10 ranking of global semiconductor foundries of 2017, TSMC ranks first with market share of 55.9%, Retrieved June 15, 2024, from: https://www.trendforce.com/presscenter/news/20171129-9922.html
    Toyota, (April 3, 2019). Toyota promotes global vehicle electrification by providing nearly 24,000 licenses royalty-free, Retrieved December 31, 2022, from: https://global.toyota/en/newsroom/corporate/27512455.html
    TrendForce, (June 13, 2024). Contract price increases offset seasonal slump, boosting DRAM Q1 revenue by 5.1%, says TrendForce. TrendForce, Retrieved June 14, 2024, from: https://www.trendforce.com/presscenter/news/20240613-12188.html
    UMC, (April 18, 2016). 2015 annual report. FORM 20-F, Retrieved August 10, 2024, from: https://www.umc.com/upload/media/08_Investors/Annual_Reports/Form-20_pdf_chi/Form_20-F_December_31_2015.pdf
    UMC, (October 29, 2020). UMC and US Department of Justice reach plea agreement on trade secret case, Retrieved June 15, 2024, from: https://www.umc.com/en/News/press_release/Content/corporate/20201029a
    UMC, (November 26, 2021). Micron and UMC announce global settlement, Retrieved May 2, 2024, from: https://www.umc.com/en/News/press_release/Content/corporate/20211126
    UMC, (April 28, 2022). 2021 annual report. FORM 20-F, Retrieved May 12, 2024, from: https://www.umc.com/upload/media/08_Investors/Annual_Reports/Form-20_pdf_chi/Form_20-F_December_31_2021.pdf
    UMC, (April 25, 2024). 2023 annual report. FORM 20-F, Retrieved May 9, 2024, from: https://www.umc.com/upload/media/08_Investors/Annual_Reports/Form-20_pdf_eng/Form_20-F_December_31_2023.pdf
    Unified Patent, (January 5, 2023). 2022 patent dispute report, Retrieved April 8, 2024, from: https://www.unifiedpatents.com/insights/2023/1/4/2022-patent-dispute-report
    United States Court of Appeals for the Federal Circuit, (September 15, 2020). In re: HP INC., Petitioner. ON PETITION AND MOTION, No. 2020-140, Retrieved May 23, 2024, from: https://cafc.uscourts.gov/sites/default/files/opinions-orders/20-140.ORDER.9-15-2020_1652640.pdf
    United States Court of Appeals for the Ninth Circuit, (February 13, 2020). Federal Trade Commission v. Qualcomm Inc, Retrieved February 21, 2024, from: https://cdn.ca9.uscourts.gov/datastore/opinions/2020/08/11/19-16122.pdf
    United States District Court for the Northern District of Alabama, (Augustst 17, 2007), iRobot Corporation v. Robotic FX, Inc., 2:07-cv-01511, Retrieved April 18, 2024, from: https://storage.courtlistener.com/recap/gov.uscourts.alnd.120006/gov.uscourts.alnd.120006.1.0.pdf
    United States District Court for the Northern District of California, (December 5, 2017). Micron Technology, Inc. v. United Microelectronics Corporation. No. 3:17-CV-06932, Retrieved May 6, 2024, from: https://storage.courtlistener.com/recap/gov.uscourts.cand.320086/gov.uscourts.cand.320086.1.0_2.pdf
    United States District Court for the Northern District of California, (September 27, 2018b). United States v. United Microelectronics Corporation, et al., CR-18-465 (LHK/SVK), Retrieved May 6, 2024, from: https://s3.documentcloud.org/documents/5026546/UMC-Theft-Indictment.pdf
    United States District Court for the Northern District of California, (November 1, 2018c). United States v. United Microelectronics Corporation, et al., No. 18-CV-06643, Retrieved May 6, 2024, from: https://www.justice.gov/usao-ndca/press-release/file/1107346/dl
    United States District Court for the Northern District of California, San Francisco Division, (October 28, 2020). Sentencing memorandum of behalf of defendant United Microelectronics Corporation. Case No. 3:18-CR-00465-MMC, Retrieved June 15, 2024, from: https://regmedia.co.uk/2020/10/23/umc_doj_sentencing_memo.pdf
    United States District Court for the Southern District of New York, (November 16, 2007). Keryx Biopharmaceuticals, Inc. v. Panion & BF Biotech, Inc., No. 1:07-cv-10376, Retrieved April 19, 2024, from: https://storage.courtlistener.com/recap/gov.uscourts.nysd.316813.1.0.pdf
    United States District Court of Massachusetts, (May 3, 2005a). iRobot Corporation v. Urus Industrial Corporation et al., No.: 1:05-cv-10914, Retrieved April 18, 2024, from: https://storage.courtlistener.com/recap/gov.uscourts.mad.97875.1.0.pdf
    United States District Court of Massachusetts, (August 8, 2005b). iRobot Corporation v. Urus Industrial Corporation et al., No.: 05CV10914 RGS, Retrieved April 18, 2024, from: https://storage.courtlistener.com/recap/gov.uscourts.mad.97875.2.0.pdf
    United States District Court of Massachusetts, (December 21, 2007b). Order entering stipulated consent judgment and proposed permanent injunction, filed as Dkt No. 88 in iRobot Corporation v Jameel Ahed and Robotic FX, Inc., 1:07-cv-11611, Retrieved April 18, 2024, from: https://www.yumpu.com/en/document/read/38505977/massachusetts-stipulated-consent-judgment-xconomy
    United States District Court of Massachusetts, (April 17, 2017). iRobot v. Matsutek, No.: 1:17-cv-10649, Retrieved April 18, 2024, from: https://iknow.stpi.narl.org.tw/Post/Files/complaint/complaint_pclass_13390_iRobot_v_Bissell.pdf
    United States District Court of Massachusetts, (December 18, 2017). Matsutek v. iRobot, No.: 1:17-cv-12483, Retrieved March 18, 2024, from: https://iknow.stpi.narl.org.tw/Post/Files/complaint/complaint_pclass_14055_Matsutek_Enterprises_v_iRobot.pdf
    United States Federal Trade Commission, (2017). Agreements filed with the federal trade commission under the medicare prescription drug, improvement, and modernization Act of 2003：Overview of agreements filed in FY 2017 a report by the Bureau of Competition, Retrieved November 5, 2023, from: https://www.ftc.gov/system/files/documents/reports/agreements-filed-federal-trade-commission-under-medicare-prescription-drug-improvement-modernization/mma_report_fy2017.pdf
    United States Trade Representative Executive Office of the President, (March 22, 2018). President Trump announces strong actions to address China’s unfair trade, Retrieved June 26, 2024, from: https://ustr.gov/about-us/policy-offices/press-office/press-releases/2018/march/president-trump-announces-strong
    U.S. Department of Commerce, (October 29, 2018). Addition of Fujian Jinhua Integrated Circuit Company, Ltd (Jinhua) to the Entity List, Retrieved June 14, 2024, from: https://2017-2021.commerce.gov/news/press-releases/2018/10/addition-fujian-jinhua-integrated-circuit-company-ltd-jinhua-entity-list.html
    U.S. Department of Justice, (November 1, 2018a). PRC state-owned company, Taiwan company, and three Individuals charged with economic espionage, Retrieved May 5, 2024, from: https://www.justice.gov/opa/pr/prc-state-owned-company-taiwan-company-and-three-individuals-charged-economic-espionage
    U.S. Department of Justice, (July 16, 2018b). Former assistant attorney general of the United States Leslie R. Caldwell, Retrieved May 7, 2024, from: https://www.justice.gov/archives/criminal/staff-profile/former-assistant-attorney-general-leslie-r-caldwell
    U.S. Department of Justice, (October 28, 2020). Taiwan company pleads guilty to trade secret theft in criminal case involving PRC state-owned company, Retrieved May 5, 2024, from: https://www.justice.gov/opa/pr/taiwan-company-pleads-guilty-trade-secret-theft-criminal-case-involving-prc-state-owned
    U.S. International Trade Commission (ITC), (2017b). Investigation No. 337-1057, ITC website, Retrieved April 23, 2024, from: https://ids.usitc.gov/case/4540/investigation/4540
    U.S. International Trade Commission (ITC), (January 9, 2018a). Initial determination granting motion to terminate the investigation as to respondents the Black & Decker Corporation and Black & Decker (U.S.) Inc., Investigation No. 337-TA-1057, Retrieved March 21, 2024, from: https://iknow.stpi.narl.org.tw/Post/Files/complaint/complaint_pclass_14133_ID_Granting_Motion_Terminate_BlackDecker.pdf
    U.S. International Trade Commission (ITC), (January 16, 2018b). Complainant’s unopposed motion to terminate Matsutek pursuant to Commission Rule 210.21(b). Investigation No. 337-TA-1057, Retrieved March 18, 2024, from: https://iknow.stpi.narl.org.tw/post/Files/complaint/complaint_pclass_14133_Complainants%20Unopposed%20Motion%20to%20Terminate%20Matsutek.pdf
    USPTO. (2022). PTAB trial statistics FY22 end of year outcome roundup IPR, PGR. In United States Patent and Trademark Office: 1-17, Retrieved November 8, 2023, from: https://www.uspto.gov/sites/default/files/documents/ptab__aia_fy2022_roundup.pdf
    Vestager, M. (November 26, 2020). Statement by Executive Vice-President Margrethe Vestager on the Commission decision to fine Teva and Cephalon €60.5 million for delaying entry of cheaper generic medicine: European Commission, Retrieved November 8, 2023, from: https://ec.europa.eu/commission/presscorner/detail/en/STATEMENT_20_2230
    Volkswagen, Interview with Volkswagen CEO Herbert Diess, (July 12, 2019). Volkswagen web, Retrieved November 27, 2022, from: https://www.volkswagenag.com/en/news/stories/2019/07/we-expect-synergy-effects-of-several-hundred-million-dollars.html
    Watanabe, S. (2022). Why recommend SMEs to join IPwe’s Smart Pools?, Retrieved May 8, 2023, from: https://watanabe-rc.com/2022/03/11/why-recommend-smes-to-join-ipwes-smart-pools/
    Weintraub, A. (2020). Roche hooks up with Gilead for Actemra-remdesivir combo trial in COVID-19, FIERCE Pharma, Retrieved August 3, 2023, from: https://www.fiercepharma.com/pharma/roche-hooks-up-gilead-for-actemra-remdesivir-combo-trial-covid-19
    Wellcome, (2020). Publishers make coronavirus (COVID-19) content freely available and reusable, Retrieved January 1, 2023, from: https://wellcome.org/press-release/publishers-make-coronavirus-covid-19-content-freely-available-and-reusable
    WEMOS. (June 27, 2022). Covid-19 technology access pool (C-TAP), Retrieved August 3, 2023, from: https://covid19response.org/c-tap/
    Wikinews, (January 15, 2005). IBM releases 500 patents to open source community, Retrieved December 31, 2022, from: https://en.wikinews.org/wiki/IBM_Releases_500_patents_to_open_source_community
    Wikipedia, (2024). John Crowley (businessman), Retrieved June 19, 2024, from: https://en.wikipedia.org/wiki/John_Crowley_(businessman)
    Wise, J. & Shapiro, M. (2023). Fish & Richardson cashes in as big tech’s go-to trial law firm. Bloomberg Law, Retrieved April 20, 2024, from: https://news.bloomberglaw.com/business-and-practice/fish-richardson-cashes-in-as-big-techs-go-to-trial-law-firm
    Wolfsburg, (May 28, 2020). Landmark in Volkswagen-Ford global alliance, Volkswagen web, Retrieved November 27, 2022, from: https://www.volkswagenag.com/en/news/2020/05/Volkswagen-Ford_global_alliance.html
    Wolfsburg, (March 14, 2022). Volkswagen and Ford expand collaboration on MEB electric platform, Volkswagen website, Retrieved November 27, 2022, from: https://www.ipwatchdog.com/2021/04/11/mrna-ip-competitive-landscape-one-year-covid-19-pandemic-part/id=132130/
    Worldometer, (January 21, 2024). COVID-19 coronavirus pandemic, Retrieved January 21, 2024, from: https://www.worldometers.info/coronavirus/
    Wu, A., (May 17, 2016). TrendForce reports falling prices caused global DRAM revenue to drop 16.6% in first quarter. TrendForce, Retrieved June 14, 2024, from: https://www.trendforce.com/presscenter/news/20160517-9388.html
    Zhou C., (December 7, 2023). CATL says Ford project on track despite new U.S. battery rules, NIKKEI Asia, Retrieved December 27, 2023, from: https://asia.nikkei.com/Business/Technology/CATL-says-Ford-project-on-track-despite-new-U.S.-battery-rules
    Antonopoulos, A. M. & Wood, G.，(2018)。精通以太坊（英：Mastering Ethereum）。O'Reilly Media, Inc.，上網日期2022年12月31日，檢自：https://cypherpunks-core.github.io/ethereumbook_zh/
    Apple，(2020年4月10日)，Apple 和 Google 合作開發新冠肺炎接觸史追蹤技術，Apple官網，上網日期2022年11月27日，檢自：https://www.apple.com/tw/newsroom/2020/04/apple-and-google-partner-on-covid-19-contact-tracing-technology/
    Apple，(2023年5月2日)，Apple 與 Google 領銜制定產業規範，處理不明追蹤，Apple官網，上網日期2023年7月13日，檢自：https://www.apple.com/tw/newsroom/2023/05/apple-google-partner-on-an-industry-specification-to-address-unwanted-tracking/
    AUO友達光電，(2023年3月)，反托拉斯法律遵循政策，上網日期2023年11月22日，檢自：https://csr.auo.com/tw/clone/58/AUO%E5%8F%8D%E6%89%98%E6%8B%89%E6%96%AF%E6%B3%95%E5%BE%8B%E9%81%B5%E5%BE%AA%E6%94%BF%E7%AD%96v2023_%E7%B9%81%E4%B8%AD%E7%89%88.pdf
    BBC，(2021年4月6日)，谷歌甲骨文訴訟終審：安卓系統「抄襲有理」裁決的利弊辯論，NEWS 中文，上網日期2024年1月20日，檢自：https://www.bbc.com/zhongwen/trad/business-56646181
    Huang, K.，(2022年8月5日)，基因線上、慶辰生技論壇，揭開全球專利鏈結、生技估值授權策略！基因線上GENEONLINE，上網日期2024年3月6日，檢自：https://geneonline.news/biotech-patent-and-ip-forum/
    iRobot, (2024). iRobot官網，歷史沿革，上網日期2024年3月19日，檢自：https://www.irobot.com.tw/About-iRobot/Company-information/History
    Jeff，(2018)，Supra≠Z4！Toyota與BMW研發團隊已多年沒有接觸，u-car官網，上網日期2023年8月13日，檢自：https://news.u-car.com.tw/news/article/43637?utm_source=news&utm_medium=related&utm_name=45037&utm_content=article
    Jeff，(2020)，擁有374匹馬力、與Toyota合作開發，BMW公開i Hydrogen NEXT氫燃料電池動力細節，u-car官網，上網日期2023年8月13日，檢自：https://news.u-car.com.tw/news/article/61671
    Ke, V.，(2021)，避免無謂的商業授權費，搞懂LGPL與GPL的不同，上網日期2022年12月31日，檢自：https://progressbar.tw/posts/97
    May，(2021年3月10日)，達成和解！以股作價 大立光換得先進光15.2%股權，科技產業資訊室，科技政策研究與資訊中心，國家實驗研究院，上網日期2024年5月16日，檢自：https://iknow.stpi.narl.org.tw/Post/Read.aspx?PostID=17585
    Micron，(2017年3月21日)，Micron 宣布在台成立 DRAM 卓越製造中心，上網日期2024年6月26日，檢自：https://investors.micron.com/static-files/a2f95d3c-c8b3-4af2-9b7b-d0cfefc6dcd1
    Microsoft, (2024)，加入合作夥伴計劃，上網日期2024年5月31日，檢自：https://partner.microsoft.com/zh-hk/community/hk-partner-hub/join-partner-program
    MoneyDJ理財網，(2024a年1月24日)，授權金開始進帳，昱展董座眼中比薪水更重要的事，上網日期2024年4月29日，檢自：https://www.youtube.com/watch?v=frk_h2thvAk&t=1s
    MoneyDJ理財網，(2024b年3月12日)，Ep.180 昱展(6785)掛牌就翻倍漲，"新劑型新藥"到底夯什麼?，上網日期2024年7月3日，檢自：https://www.youtube.com/watch?v=MKP3xZVri7g
    USTV 非凡電視，(2021年12月2日)，和解變夥伴！美光.聯電簽長約"三贏局面" 背後功臣群聯潘健成？，非凡財經新聞，上網日期2024年5月3日，檢自：https://www.youtube.com/watch?v=KechbPJoUxg&t=11s
    Yeh, D.，(2020)，蘋果、Google手機平台內建新冠肺炎暴露通知，無需下載App就可接收警報，數位時代，上網日期2022年11月27日，檢自：https://www.bnext.com.tw/article/59079/apple-google-coronavirus-exposure-notification-contact-tracing-app-system
    久禾光，(2024年3月13日)，代重要子公司江蘇久禾光電有限公司公告民事訴訟，重大訊息，上網日期2024年7月13日，檢自：https://mops.twse.com.tw/mops/web/t05st01
    久禾光，(2024年4月30日)，112年度年報，上網日期2024年7月13日，檢自：https://ptic.com.tw/-pub/user_files/investor/zh-tw/%E8%82%A1%E6%9D%B1%E6%9C%83%E7%9B%B8%E9%97%9C/112%E5%B9%B4%E4%B9%85%E7%A6%BE%E5%85%89%E9%9B%BB%E5%B9%B4%E5%A0%B1.pdf
    大立光電股份有限公司，(2013a年3月25日)，合併財務報表民國101年及100年12月31日，上網日期2024年7月28日，檢自：https://www.largan.com.tw/download/quarterly/2012-101Season4.pdf
    大立光電股份有限公司，(2013b年4月23日)，101年度年報，上網日期2024年7月28日，檢自：https://www.largan.com.tw/download/annual/2012-101.pdf
    大立光電股份有限公司，(2013c年9月25日)，本公司對先進光聲請假扣押之說明，重大訊息，上網日期2024年7月28日，檢自：https://mops.twse.com.tw/mops/web/t05st01
    大立光電股份有限公司，(2013d年10月25日)，本公司對先進光聲請假處分 強制執行暨提起本案訴訟之說明，重大訊息，上網日期2024年7月28日，檢自：https://mops.twse.com.tw/mops/web/t05st01
    大立光電股份有限公司，(2021a年2月23日)，本公司對先進光電科技股份有限公司進行假執行之說明，重大訊息，公開資訊觀測站，上網日期2024年5月13日，檢自：https://mops.twse.com.tw/mops/web/t05st01
    大立光電股份有限公司，(2021b年3月5日)，本公司與先進光電科技股份有限公司針對營業秘密侵害相關案件達成和解，重大訊息，公開資訊觀測站，上網日期2024年5月13日，檢自：https://mops.twse.com.tw/mops/web/t05st01
    大立光電股份有限公司，(2021c年3月9日)，公告董事會決議參與認購先進光電科技股份有限公司私募普通股，重大訊息，公開資訊觀測站，上網日期2024年5月13日，檢自：https://mops.twse.com.tw/mops/web/t05st01
    大立光電股份有限公司，(2022年2月10日)，個體財務報告暨會計師查核報告 民國110年度及109年度，2024年7月28日檢自：https://www.largan.com.tw/download/quarterly/2021-110Parent.pdf
    大立光電股份有限公司，(2023年4月24日)，2022年年報，上網日期2024年5月15日，檢自：https://www.largan.com.tw/download/shareholder/%E5%B9%B4%E5%A0%B1-%E4%BF%AE%E8%A8%82.pdf
    工商時報，(2021年12月3日)，聯電、美光合作 外資點名「他」是大贏家，上網日期2024年6月27日，檢自：https://www.ctee.com.tw/news/20211203700565-430298
    文永順，(2024a年3月13日)，20240313昱展新藥_元大證券舉辦之「第一季投資論壇」，昱展新藥生技股份有限公司，上網日期2024年4月29日，檢自：https://www.youtube.com/watch?v=JaBu4J5ADN4
    王志鈞，(2018年5月15日)，一堂300萬美金的專利課：松騰實業 以專利權逼和美國掃地機大廠，工業技術與資訊月刊，318期5月號，上網日期2022年6月11日，檢自：https://www.itri.org.tw/ListStyle.aspx?DisplayStyle=18_content&SiteID=1&MmmID=1036452026061075714&MGID=1001035403074601641
    王惠瑜，(2019年3月20日)，CRISPR技術的專利戰！張鋒與 Jennifer Doudna 間專利的龍爭虎鬥，泛科學 PanSci，上網日期2023年12月29日，檢自：https://pansci.asia/archives/149097
    王曉玟，(2010年1月27日)，台積電　不消滅中芯的祕密—智財戰換中國半導體江山，天下雜誌，第440期，上網日期2024年7月29日，檢自：https://www.cw.com.tw/index.php/article/5111063?from=search
    公平交易委員會，(2019年11月12日)，國際潮流下我國反托拉斯法執法規範與走向—我國對於卡特爾(聯合)行為規範及案例分析，上網日期2023年11月19日，檢自：https://www.ftc.gov.tw/upload/38df325b-a8d8-4847-bafa-c3e7c416612f.pdf
    中央社，(2019年12月13日)，正版告輸山寨 國際品牌在中國商標專利戰頻吃癟，上網日期2024年1月1日，檢自：https://www.cna.com.tw/news/firstnews/201912130210.aspx
    中央社，(2023年12月21日)，瑞幸咖啡被山寨又被索賠近90億 疑似中國人設局，上網日期2024年1月1日，檢自：https://tw.news.yahoo.com/%E7%91%9E%E5%B9%B8%E5%92%96%E5%95%A1%E8%A2%AB%E5%B1%B1%E5%AF%A8%E5%8F%88%E8%A2%AB%E7%B4%A2%E8%B3%A0%E8%BF%9190%E5%84%84-%E7%96%91%E4%BC%BC%E4%B8%AD%E5%9C%8B%E4%BA%BA%E8%A8%AD%E5%B1%80-072126490.html
    中國國家藥品監督管理局，(2023)，2023年10月27日藥品批准證明檔送達資訊發佈，上網日期2024年3月7日，檢自：https://www.nmpa.gov.cn/zwfw/sdxx/sdxxyp/yppjfb/20231027160158106.html
    中華民國會計研究發展基金會，(2012年4月25日)，無形資產之評價準則公報第七號，審計準則公報制定之目的與架構，上網日期2024年2月17日，檢自：https://www.ardf.org.tw/html/opinion/av007.pdf
    司法院，(2012年5月7日)，司法院101年度「智慧財產法律座談會 民事訴訟類相關議題」提案及研討結果第6號，上網日期2024年2月23日，檢自：https://web.law.ntpc.gov.tw
    司法院，(2022年11月9日)，何謂「秘密保持命令」？，司法院全球資訊網，常見問答，上網日期2023年12月19日，檢自：https://www.judicial.gov.tw/tw/cp-1654-707188-c6c2e-1.html
    全國工業總會智慧財產權委員會，(2022年7月1日)，1110624『創新智權運用 IP Bank 借東風 國際談判佔上風』線上座談會，上網日期2024年6月20日，檢自：https://www.youtube.com/watch?v=0guLtJHduz0&t=8386s
    台中市政府經濟發展局，(2023年11月6日)，最大外商加碼投資！美光台中四廠開幕 盧市長：一光一電商機無限，台中市政府，上網日期2024年6月26日，檢自：https://www.taichung.gov.tw/2493959/post
    台積電，(2020年5月15日)，台積公司宣布有意於美國設立先進晶圓廠，上網日期2024年6月26日，檢自：https://pr.tsmc.com/chinese/news/2033
    台積電，(2022年12月6日)，台積公司宣布亞利桑那州晶圓廠擴建計畫，上網日期2024年6月26日，檢自：https://pr.tsmc.com/chinese/news/2977
    台積電，(2023年)，台積公司111年度永續報告書，上網日期2024年4月12日，檢自：https://esg.tsmc.com/download/file/2022_sustainabilityReport/chinese/c-all.pdf#page=47
    台積電，(2024年4月8日)，TSMC Arizona與美國商務部宣布最高可達66億美元的晶片法案直接補助，該公司並計畫在鳳凰城設立第三座先進晶圓廠—第三座晶圓廠將生產美國最先進的尖端半導體，台積公司在亞利桑那州的總投資金額將超過650億美元，上網日期2024年6月26日，檢自：https://pr.tsmc.com/chinese/news/3122
    自由時報，(2022年3月10日)，徹查中資挖角、竊密// 8家中企 調局大搜索，財經政策，上網日期2022年5月31日，檢自：https://ec.ltn.com.tw/article/paper/1504945
    朱家儀，(2020年4月11日)，蘋果、Google罕見合作：將開發軟體以手機警示用戶「是否曾接觸感染者」，The News Lens關鍵評論，上網日期2022年11月27日，檢自：https://www.thenewslens.com/article/133696
    朱翊瑄，何謂「美國專利審理暨訴願委員會（PTAB）」? 資訊工業策進會，科技法律研究所，上網日期2022年5月24日，檢自： https://stli.iii.org.tw/article-detail.aspx?no=57&tp=5&d=8144
    江星翰，(2022年10月15日)，藥物基因檢測專利授權涉違約　世基怒告中研院求償3億，鏡週刊，上網日期2024年1月5日，檢自：https://www.mirrormedia.mg/story/20221010fin004
    先進光電科技股份有限公司，(2012年5月25日)，100年度年報，上網日期2024年7月28日，檢自：https://www.aoet.com.tw/investor
    先進光電科技股份有限公司，(2013年9月24日)，公告大立光電股份有限公司對本公司提起假扣押說明，重大訊息，上網日期2024年7月28日，檢自：https://mops.twse.com.tw/mops/web/t05st01
    先進光電科技股份有限公司，(2021a年2月23日)，大立光電股份有限公司聲請假執行本公司對於第三人薩摩亞群島商Excellence Electro-Optical Technology股份有限公司等公司之債權，重大訊息，公開資訊觀測站，上網日期2024年5月13日，檢自：https://mops.twse.com.tw/mops/web/t05st01
    先進光電科技股份有限公司，(2021b年3月5日)，本公司與大立光電股份有限公司針對營業秘密侵害相關案件達成和解，重大訊息，公開資訊觀測站，上網日期2024年5月13日，檢自：https://mops.twse.com.tw/mops/web/t05st01
    先進光電科技股份有限公司，(2021c年3月5日)，本公司對訴訟案公開說明，重大訊息，公開資訊觀測站，上網日期2024年5月13日，檢自：https://mops.twse.com.tw/mops/web/t05st01
    先進光電科技股份有限公司，(2021d年3月15日)，本公司有價證券近期多次達公佈注意交易資訊標準，故公告相關訊息，以利投資人區別瞭解，重大訊息，公開資訊觀測站，上網日期2024年5月13日，檢自：https://mops.twse.com.tw/mops/web/t05st01
    先進光電科技股份有限公司，(2021e年5月15日)，2020年報，上網日期2024年5月19日，檢自：https://www.aoet.com.tw/investor
    先進光電科技股份有限公司，(2022a年3月17日)，合併財務報告暨會計師查核報告 民國110年度及109年度，上網日期2024年7月28日檢自：https://www.aoet.com.tw/investor
    先進光電科技股份有限公司，(2022b年4月18日)，本公司對久禾光電股份有限公司等二人，向智慧財產及商業法院提起專利侵權訴訟，重大訊息，公開資訊觀測站，上網日期2024年7月3日，檢自：https://mops.twse.com.tw/mops/web/t05st01
    先進光電科技股份有限公司，(2023年4月30日)，2022年度年報，上網日期2024年5月15日，檢自：https://www.aoet.com.tw/investor
    先進光電科技股份有限公司，(2024年4月30日)，112年度年報，上網日期2024年7月28日，檢自：https://doc.twse.com.tw/pdf/2023_3362_20240620F04_20240729_171023.pdf
    何美如，(2024年6月11日)，昱展ALA-1000列授權夥伴主開發項目發展可期，陸授權拚今年完成，財訊快報，上網日期2024年7月3日，檢自：https://tw.stock.yahoo.com/news/%E6%98%B1%E5%B1%95ala-1000%E5%88%97%E6%8E%88%E6%AC%8A%E5%A4%A5%E4%BC%B4%E4%B8%BB%E9%96%8B%E7%99%BC%E9%A0%85%E7%9B%AE%E7%99%BC%E5%B1%95%E5%8F%AF%E6%9C%9F-%E9%99%B8%E6%8E%88%E6%AC%8A%E6%8B%9A%E4%BB%8A%E5%B9%B4%E5%AE%8C%E6%88%90-040447490.html
    阿恰卡，(2021年4月21日)，Ford全新SUV蓋頭蓋尾仍被抓包　但骨子裡竟然是Volkswagen? 聯合新聞網，發燒車訊，上網日期2022年11月27日，檢自：https://autos.udn.com/autos/story/7826/5396736
    吳明潔，2018年9月17日，小蝦米掃射大鯨魚 松騰實業董事長燕成祥，鏡週刊，頭家開講，上網日期2024年3月19日，檢自：https://www.youtube.com/watch?v=PY-_wtKRago&t=150s
    吳家豪，(2022年12月19日)，大立光在廈門提告 玉晶光否認侵犯專利權，中央社，上網日期2023年12月26日，檢自：https://www.cna.com.tw/news/afe/202212190059.aspx
    吳培安，(2024年1月26日)，「臺灣抗體之父」張子文 免疫功坊 2024兩藥進臨床，環球生技月刊，第113期，上網日期2024年3月8日，檢自：https://news.gbimonthly.com/tw/magazine/article_show.php?num=64567
    李承儒，(2020年7月11)，Ford與Volkswagen合作之雙福聯盟正式啟動！合作產品規劃公布！CARTURE車勢文化，上網日期2022年11月27日，檢自：https://www.carture.com.tw/opinion/article/10333-Ford%E8%88%87Volkswagen%E5%90%88%E4%BD%9C%E4%B9%8B%E9%9B%99%E7%A6%8F%E8%81%AF%E7%9B%9F%E6%AD%A3%E5%BC%8F%E5%95%9F%E5%8B%95%EF%BC%81%E5%90%88%E4%BD%9C%E7%94%A2%E5%93%81%E8%A6%8F%E5%8A%83%E5%85%AC%E5%B8%83%EF%BC%81
    李純君，(2021年12月3日)，聯電證實將成為美光直接供應商，美光獲得新增28奈米產能奧援，財訊快報，上網日期2024年6月27日，檢自：https://tw.stock.yahoo.com/news/%E8%81%AF%E9%9B%BB%E8%AD%89%E5%AF%A6%E5%B0%87%E6%88%90%E7%82%BA%E7%BE%8E%E5%85%89%E7%9B%B4%E6%8E%A5%E4%BE%9B%E6%87%89%E5%95%86-%E7%BE%8E%E5%85%89%E7%8D%B2%E5%BE%97%E6%96%B0%E5%A2%9E28%E5%A5%88%E7%B1%B3%E7%94%A2%E8%83%BD%E5%A5%A7%E6%8F%B4-023116952.html
    李涓榕及李晶晶，(2021年12月24日)，王美花談聯電美光和解：有助半導體與記憶體在台落地生根，新唐人亞太台，上網日期2024年5月3日，檢自：https://www.ntdtv.com.tw/b5/20211224/video/314047.html?%E7%8E%8B%E7%BE%8E%E8%8A%B1%E8%AB%87%E8%81%AF%E9%9B%BB%E7%BE%8E%E5%85%89%E5%92%8C%E8%A7%A3%EF%BC%9A%E6%9C%89%E5%8A%A9%E5%8D%8A%E5%B0%8E%E9%AB%94%E8%88%87%E8%A8%98%E6%86%B6%E9%AB%94%E5%9C%A8%E5%8F%B0%E8%90%BD%E5%9C%B0%E7%94%9F%E6%A0%B9
    李淑蓮，(2022年7月27日)，台積電的國際智權贏家策略，北美智權報，第313期，上網日期2024年7月1日，檢自：http://www.naipo.com/Portals/1/web_tw/Knowledge_Center/Industry_Economy/IPNC_220727_0701.htm
    李淑蓮，(2022年11月19日)，台積電營業秘密註冊制度的「三要、三不要」，北美智權報，第320期，上網日期2024年4月12日，檢自：http://www.naipo.com/Portals/1/web_tw/Knowledge_Center/Industry_Economy/IPNC_221109_0701.htm
    杜蕙蓉，(2023年10月13日)，林東和、Indivior從冤家變戰略伙伴，工商時報，上網日期2024年7月3日，檢自：https://www.ctee.com.tw/news/20231013700162-439901
    林宏文，(2013年10月10日)，台灣生技創投十年起伏 老幹新枝，環球生技雜誌，第4期，2024年6月25日，檢自：https://news.gbimonthly.com/tw/magazine/article_show.php?num=41438
    林宏達，(2018年11月15日)，還原聯電案關鍵21天內幕，財訊雙週刊，第568期，上網日期2024年5月7日，檢自：https://www.wealth.com.tw/articles/3148d82f-7bb0-49d3-892a-b92357bfd8a6
    林宗輝，(2021年12月8日)，和解幕後》聯電、美光訴訟輕輕放下 竟與「糧食危機」有關，財訊雙週刊，第648期，上網日期2024年5月3日，檢自：https://www.wealth.com.tw/articles/06443eb8-2ad5-44ac-8c88-de897aa4a0b3?_trms=cf829b6fdfb2bbe4.1714664985180
    林信男，(2021年11月19日)，圍魏救趙iRobot控告侵權　這家台灣公司如何聯手工研院「一劍鎖喉」，讓對方妥協撤告？，今周刊，上網日期2024年3月19日，檢自：https://www.businesstoday.com.tw/article/category/80392/post/202111190034/
    林洧楨，(2018年3月18日)，掃地機專利殲滅戰 唯一活口就在台灣！，商業周刊，上網日期2024年3月30日，檢自：https://today.line.me/tw/v2/article/jazvnL
    林洧楨，(2022年8月25日)，全球第二大掃地機器人代工廠 擁專利救公司！松騰以戰逼和龍頭變全球二哥，商業周刊，第1815期，上網日期2024年4月22日，檢自：https://www.businessweekly.com.tw/Archive/Article?StrId=7006429
    林苑卿，(2021年3月17日)，大立光9年官司和解落幕 先進光董座高維亞第一手告白：那一天，我關起門來痛哭！，財訊雙週刊，第629期，上網日期2024年5月16日，檢自：https://www.wealth.com.tw/articles/c73d965c-b1f2-4ec3-ae68-838b308173cb
    林苑卿，(2023年6月2日)，接下蘋果訂單，卻被修理得「體無完膚」...先進光啟動轉型計畫，董座：光學不再是唯一想走的路，財訊雙週刊，第686期，上網日期2024年7月13日，檢自：https://www.businesstoday.com.tw/article/category/183015/post/202306020038/
    林益民，(2022年6月13日)，獨家》美光聯電案下半場　我調查官員首度站上美國聯邦法庭作證，新新聞，上網日期2024年5月9日，檢自：https://new7.storm.mg/article/4370140
    林瑞珠，(2016)，關懷生命 擇善固執 因為堅持所以傑出—張子文，國立清華大學，上網日期2024年3月8日，檢自：https://y105.site.nthu.edu.tw/p/406-1094-91753,r5329.php?Lang=zh-tw
    林誠夏，(2012年5月14日)，更為彈性中庸的 LGPL-3.0，Open Fondary，上網日期2022年12月31日，檢自：https://ossf.denny.one/tw/legal-column-list/1166--lgpl3.html
    林薏茹，(2021年12月2日)，美光與聯電簽長約「三方歡喜」 潘健成為背後推手，鉅亨網，上網日期2024年5月3日，檢自：https://news.cnyes.com/news/id/4779293
    邱英武，(2018年12月27日)，新興科技專利國際訴訟策略 ─ 小米、松騰寶貴經驗分享，北美智權報，第227期，上網日期2024年4月20日，檢自：http://www.naipo.com/Portals/1/web_tw/Knowledge_Center/Industry_Economy/IPNC_181226_0702.htm
    周佳蓉，(2023年5月25日 )，大立光以戰逼單 築起護城河，先探投資週刊，2249期，上網日期2023年8月21日，檢自：https://udn.com/news/story/6851/7189586
    松騰，(2024)，松騰實業有限公司官網，上網日期2024年3月19日，檢自：https://www.matsutek.com/pages/milestone
    祝文明，(2018年5月18日)，“諾欣妥”專利之一緣何被宣告專利權無效？，2017年度專利複審無效十大案件，中國知識產權報，上網日期2024年3月7日，檢自：https://www.cnipa.gov.cn/2018-05/20180518091101798205.pdf
    南京生物醫藥谷，(2023年10月30日)，“心”機遇！華瀚醫藥悅欣妥®獲批上市，上網日期2024年3月7日，檢自：https://mp.weixin.qq.com/s/GujLjt4NcEl9QQjfALf6vA?fbclid=IwAR3SllQHzCt7Wu1MaVxU6qEplLiFlPFTl980gVDs1UG4GPDXOLLOBibUhVQ
    南京生物醫藥谷，(2024)，南京生物醫藥谷概況，上網日期2024年6月29日，檢自：https://www.njbpv.cn/index.php?m=content&c=index&a=lists&catid=18
    南京華訊知識產權顧問有限公司，(2023)，華瀚醫藥悅欣妥®沙庫巴曲纈沙坦鈉片獲國家藥監局批准上市，上網日期2024年3月7日，檢自：https://www.chinaipic.com/news/757.html
    南京華訊知識產權顧問有限公司，(2024)，服務簡介，上網日期2024年3月12日，檢自：https://www.chinaipic.com/about11111.html。馬瑞璿與王子承，(2020年6月23日)，「過來人」看廣明、惠普和解戲碼 認清「三件事」台企才能避踩反托拉斯法紅線，今周刊，上網日期2023年11月19日，檢自： https://www.businesstoday.com.tw/article/category/80393/post/202006230007/
    胡竹生與呂美玲，(2018年4月19日)，家用吸塵機器人的智權訴訟全貌，機械工業，上網日期2024年4月20日，檢自：https://www.automan.tw/news/newsContent.aspx?id=2089
    美光，(2018年7月15日)，美光科技就中國福建省專利訴訟案件的聲明，上網日期2024年6月15日，檢自：https://investors.micron.com/static-files/7e8d450a-d941-4f07-b33c-328b1344b9bd
    美時，(2019年2月20日)，艾威群與美時已於美國上市BUPRENORPHINE/NALOXONE舌下含片，上網日期2024年4月29日，檢自：https://www.lotuspharm.com.tw/newsroom/%E7%BE%8E%E6%99%82-bnp-%E7%BE%8E%E5%9C%8B%E4%B8%8A%E5%B8%82
    昱展新藥，(2023年10月12日)，本公司收到國際大藥廠INDIVIOR UK LIMITED通知履行ALA-1000及相關產品授權合約之選擇權，上網日期2024年4月29日，檢自：https://alarpharm.com/zh/2023-10-12-%E6%9C%AC%E5%85%AC%E5%8F%B8%E6%94%B6%E5%88%B0%E5%9C%8B%E9%9A%9B%E5%A4%A7%E8%97%A5%E5%BB%A0indivior-uk-limited%E9%80%9A%E7%9F%A5%E5%B1%A5%E8%A1%8Cala-1000%E5%8F%8A%E7%9B%B8%E9%97%9C%E7%94%A2/
    昱展新藥，(2024a年5月2日)，112年年報，上網日期2024年7月3日，檢自：https://alarpharm.com/wp-content/uploads/112%E5%B9%B4%E5%A0%B1.pdf
    昱展新藥，(2024b)，股東專區—股利，上網日期2024年7月3日，檢自：https://alarpharm.com/zh/%e6%8a%95%e8%b3%87%e4%ba%ba%e5%b0%88%e5%8d%80/%e8%82%a1%e6%9d%b1%e5%b0%88%e5%8d%80/
    昱展新藥，(2024c)，20240612 昱展新藥受邀參加群益金鼎證券舉辦之台股生技產業企業日，上網日期2024年7月3日，檢自：https://www.youtube.com/watch?v=uLWezNazR3g&t=159s
    段詩潔，(2023年12年27日)，7歲本土小公司如何靠戒毒癮藥，創台灣生技授權金新高？故事要從「1輛速霸陸一開20年」昱展老董說起，今週刊，第1410期，上網日期2024年4月30日，檢自：https://www.businesstoday.com.tw/article/category/183015/post/202312270008/
    財訊，(2021年3月29日)，先進光、大立光9年官司和解落幕！高維亞第一手血淚告白，聽了財知道 《Wealth Known》EP26，上網日期2024年5月19日，檢自：https://www.youtube.com/watch?v=KTApHRGsQJ0
    財訊，(2021年12月23日)，大立光戰聯想3》專利戰影響大 這公司當年逼和iRobot，財訊雙週刊，第469期，上網日期2024年4月20日，檢自：https://www.wealth.com.tw/articles/6c4c8218-cc8e-4959-b1ca-01d5b612a7c6
    高適，(2023年5月17日)，大立光大打車用專利戰，先進光成間接受惠者！，理財周刊，上網日期2024年7月29日，檢自：https://www.moneyweekly.com.tw/ArticleData/Info/Article/112679
    張永立，(2001年2月6日)，單株抗體先驅，Tanox綻放華人生技製藥光芒，寶來證券，MoneyDJ理財網，上網日期2024年3月8日，檢自：https://www.moneydj.com/z/zu/zua/zuab/zuabz_23B4C691-2FA0-493B-8DE4-171C9578AE51.djhtm
    張旭，(2020年1月22日)，[捉對]本是同根生、但各自表述的駕馭魅力─BMW Z4與Toyota GR Supra，u-car官網，上網日期2023年8月20日，檢自：https://roadtest.u-car.com.tw/roadtest/article/50468
    張建中，(2024年5月25日)，潘健成白手創業34歲登股王 看好未來AI應用服務【專訪】，中央社，上網日期2024年6月27日，檢自：https://www.cna.com.tw/news/ait/202405250029.aspx?_trms=8b6ef2e487d8bfcd.1719458016481
    張漢綺，(2023年4月14日)，《光電股》獨立發展 林恩平：大立光不會合作先進光，時報資訊，上網日期2024年7月28日檢自：https://tw.stock.yahoo.com/news/%E5%85%89%E9%9B%BB%E8%82%A1-%E7%8D%A8%E7%AB%8B%E7%99%BC%E5%B1%95-%E6%9E%97%E6%81%A9%E5%B9%B3-%E5%A4%A7%E7%AB%8B%E5%85%89%E4%B8%8D%E6%9C%83%E5%90%88%E4%BD%9C%E5%85%88%E9%80%B2%E5%85%89-001509790.html
    張漢綺，(2024年7月23日)，《光電股》先進光砸逾11億元取得康寧中科廠 今年營收拚新高，時報資訊，上網日期2024年7月29日，檢自：https://tw.stock.yahoo.com/news/%E5%85%89%E9%9B%BB%E8%82%A1-%E5%85%88%E9%80%B2%E5%85%89%E7%A0%B8%E9%80%BE11%E5%84%84%E5%85%83%E5%8F%96%E5%BE%97%E5%BA%B7%E5%AF%A7%E4%B8%AD%E7%A7%91%E5%BB%A0-%E4%BB%8A%E5%B9%B4%E7%87%9F%E6%94%B6%E6%8B%9A%E6%96%B0%E9%AB%98-234816774.html
    張瓊方，(2006年8月)，解救趴趴兒──陳垣崇新藥發明之路，台灣光華雜誌，上網日期2024年6月21日，檢自：https://www.taiwan-panorama.com.tw/Articles/Details?Guid=0aba8e26-a600-414f-b381-04e1ee7b7999&CatId=9&postname=%E8%A7%A3%E6%95%91%E8%B6%B4%E8%B6%B4%E5%85%92%E2%94%80%E2%94%80%E9%99%B3%E5%9E%A3%E5%B4%87%E6%96%B0%E8%97%A5%E7%99%BC%E6%98%8E%E4%B9%8B%E8%B7%AF
    曹以斌及陳仲興，(2020年11月15日)，【全文】與美司法部和解　聯電大轉向切割中國，鏡週刊，上網日期2024年5月11日，檢自：https://www.mirrormedia.mg/story/20201110fin007
    基因線上，(2023年11月16日)，華翰醫藥心臟衰竭和高血壓用藥於中國核准上市，為心臟病患提供更多治療選擇，GENEONLINE，上網日期2024年3月7日，檢自：https://geneonline.news/huahan_pharmaceutical_heart_failure_drug_nmpa_approved/
    郭明錤，(2023年2月3日)，先進光成為iPad新鏡頭供應商，與大立光合作以及出貨相機模組 (CCM) 為中長期新成長驅動，上網日期2024年7月28日檢自：https://medium.com/@mingchikuo/%E5%85%88%E9%80%B2%E5%85%89%E6%88%90%E7%82%BAipad%E6%96%B0%E9%8F%A1%E9%A0%AD%E4%BE%9B%E6%87%89%E5%95%86-%E8%88%87%E5%A4%A7%E7%AB%8B%E5%85%89%E5%90%88%E4%BD%9C%E4%BB%A5%E5%8F%8A%E5%87%BA%E8%B2%A8%E7%9B%B8%E6%A9%9F%E6%A8%A1%E7%B5%84-ccm-%E7%82%BA%E4%B8%AD%E9%95%B7%E6%9C%9F%E6%96%B0%E6%88%90%E9%95%B7%E9%A9%85%E5%8B%95-aoet-will-soon-be-the-new-lens-supplier-for-the-ee756382fa6e
    黃日燦，(2013年1月17日)，台積中芯大對決（下），經濟日報，上網日期2024年7月29日，檢自：https://udndata.com/ndapp/Story?no=1&page=1&udndbid=udndata&SearchString=JiMyMTQ4ODsmIzMxMzA5OyYjMjAwMTM7JiMzMzQ1NTsmIzIyODIzOyYjMjM1NjU7JiMyNzc3MDsrpOm0wT49MjAxMjA3MDcrpOm0wTw9MjAxNDA3MjMrs%2FinTz3BcKZYs%2Fh8uGfA2aTps%2Fh8wXCmWLHfs%2Fh8VXBhcGVy&sharepage=20&select=1&kind=2&article_date=2013-01-18&news_id=6679467
    黃亦筠，(2018年4月26日)，工研院「一劍鎖喉」　台灣掃地機器人如何告贏世界龍頭iRobot？，天下雜誌，上網日期2024年4月20日，檢自：https://www.cw.com.tw/article/5089558
    黃啟乙，(2023年3月3日)，從晶睿、立端再到先進光，有集團作靠山，不發都難！，先探雜誌，第2237期，上網日期2024年7月29日，檢自：http://www.investor.com.tw/onlineNews/freeColArticle.asp?articleNo=7032
    陳又嘉，(2022年9月16日)，松騰「超級電池」與起而行「充電樁」異業結盟 3項特色加持 全力打造松騰成為電輔車界的特斯拉，風傳媒，上網日期2024年6月12日，檢自：https://www.storm.mg/localarticle/4522251
    陳良榕，(2018年11月5日)，六個專利證據　讓美國大膽告聯電、晉華，天下雜誌，上網日期2024年5月9日，檢自：https://www.cw.com.tw/article/5092805
    陳邦禮，(2019年5月20日)，專利如何保護自己？你該想想如何攻擊對手—由掃地機器人的專利戰役談起，澄品智慧產權事務所，上網日期2024年4月20日，檢自：https://www.cp-ip.tw/news-inner.php?id=1
    陳念舜，(2020年6月28日)，研發十年磨一劍 逆全球化無招恐勝有招，CTIMES，上網日期2024年4月18日，檢自：https://www.ctimes.com.tw/DispNews/tw/2006282312GU.shtml
    陳韋帆，(2019年12月13日)，從10萬賺50億！松騰董事長談房市，三立新聞網，上網日期2024年4月18日，檢自：https://tw.news.yahoo.com/%E5%BE%9E10%E8%90%AC%E8%B3%BA50%E5%84%84-%E6%9D%BE%E9%A8%B0%E8%91%A3%E4%BA%8B%E9%95%B7%E8%AB%87%E6%88%BF%E5%B8%82-150011063.html
    陳琮勛，(2023年8月7日)，「商標蟑螂出沒！」我的商標被人搶去註冊了怎麼辦？，法律白話文運動，智財科技，上網日期2024年1月1日，檢自：https://plainlaw.me/posts/trademark-being-hijacked-for-registration
    陳曉莉，(2008年8月25日)，微軟擴大與Novell合作　加碼購買1億美元支援憑證，iThome，上網日期2023年12月4日，檢自：https://reurl.cc/L681Ya
    陳翾 & 梁尚倫，(2013年1月25日)，跑車研究今年完成，Toyota與BMW合作協議確定，u-car官網，上網日期2022年11月27日，檢自：https://news.u-car.com.tw/news/article/17954
    涂志豪，(2019年2月21日)，美光台灣DRAM卓越中心 擴陣容，工商時報，上網日期2024年6月26日，檢自：https://www.ctee.com.tw/news/20190221700075-430502
    涂志豪，(2020年10月31日)，與美光民事訴訟... 聯電法務長張振倫：有信心，工商時報，上網日期2024年5月7日，檢自：https://readers.ctee.com.tw/cm/20201031/a10aa10/1091233/share
    涂志豪及蘇嘉維，(2021年12月3日)，擴大合作 美光將成聯電新客戶 可望與群聯共創三贏，工商時報，上網日期2024年5月3日，檢自：https://www.ctee.com.tw/news/20211203700203-430502
    國家科學及技術委員會，(2023)，2019 總統科學獎得獎者—生命科學組 ─ 陳垣崇 院士，上網日期2024年6月21日，檢自：https://web.nstc.gov.tw/SciencePrize/2023/Yuan-Tsong-Chen-ch.html
    國際中橡，(2006年10月3日），本公司、Synpac (North Carolina), Inc. 及Genzyme Corporation簽訂授權合約補充協議，重大訊息，公開資訊觀測站，上網日期2024年6月20日，檢自：https://mops.twse.com.tw/mops/web/t05st01
    國際中橡，(2019a年5月5日)，代重要子公司Synpac Venture Captial, L. P.公告有關治療龐貝氏症孤兒藥專利權事宜，重大訊息，公開資訊觀測站，上網日期2024年6月20日，檢自：https://mops.twse.com.tw/mops/web/t05st01
    國際中橡，(2019b年6月4日)，本公司、子公司Synpac (North Carolina) Inc. 及SynpacVenture Capital, L.P.公告Genzyme Corporation對歐洲專利權之疑義提請仲裁，重大訊息，公開資訊觀測站，上網日期2024年6月20日，檢自：https://mops.twse.com.tw/mops/web/t05st01
    國際中橡，(2020年2月23日)，本公司、子公司Synpac (North Carolina) Inc.及SynpacVenture Capital, L.P.等公告Genzyme Corporation對美國專利權及2021年7月10日後美國地區權利金之疑義提請仲裁，重大訊息，公開資訊觀測站，上網日期2024年6月22日，檢自：https://mops.twse.com.tw/mops/web/t05st01
    國際中橡，(2021年11月11日)，本公司及子公司公告：與Genzyme Corporation之專利權利金爭議達成和解，上網日期2024年6月21日，檢自：https://www.csrcgroup.com/newsArticle.html?id=144
    國際中橡，(2022)，2022年第三季合併財報，上網日期2024年6月22日，檢自：https://www.csrcgroup.com/investors1.html?lang=tw
    彭杏朱，(2014年8月28日)，掃地機器人橫掃亞洲 市占率拚到世界第二：服務型機器人先鋒1〉松騰集團 以小搏大玩創意，遠見雜誌，9月號，第339期，上網日期2024年4月21日，檢自：https://www.gvm.com.tw/article/19543
    最嚴厲的反托拉斯制裁 友達將上訴，(2012年9月21日)，公視新聞網，上網日期2023年11月19日，檢自：https://news.pts.org.tw/article/221614
    報告揭中國駭客竊密助壯大經濟 美歐亞30企業受害，中央社，上網日期2022年5月31日，檢自：https://www.cna.com.tw/news/aopl/202205040422.aspx
    智慧財產及商業法院，智慧財產法庭民事第一審專利訴訟事件有效性抗辯成立比率，上網日期2023年12月4日，檢自：https://ipc.judicial.gov.tw/tw/dl-62121-495da7435604465ba282b0eacdb49ca4.html
    智慧財產及商業法院民事第一審訴訟事件收結及終結情形—97年第3季至112年第3季，上網日期2023年10月22日，檢自：https://ipc.judicial.gov.tw/tw/dl-62114-bb0a24a2ece64451bc2bfc8a7c96363e.html
    曾麗芳，(2018年4月20日)，松騰掃地機器人出貨衝3百萬台：專利戰與美國iRobot公司達成和解，因禍得福...，中時新聞網，上網日期2024年4月21日，檢自：https://www.chinatimes.com/newspapers/20180420000339-260204?chdtv
    楊智傑，(2022年6月22日)，蘋果電腦「Think different」商標未真正使用而廢止？歐盟法院2022年Apple v EUIPO ‐ Swatch案，北美智財權報，第311期，上網日期2022年11月27日，檢自：http://www.naipo.com/Portals/1/web_tw/Knowledge_Center/Trademark/IPNC_220622_1902.htm
    楊曉芳，(2015年2月24日)，群聯 喜迎美光大單，工商時報，上網日期2024年6月27日，檢自：https://tw.news.yahoo.com/%E7%BE%A4%E8%81%AF-%E5%96%9C%E8%BF%8E%E7%BE%8E%E5%85%89%E5%A4%A7%E5%96%AE-215021024--finance.html
    資策會科法所創意智財中心，(2023年2月1日)，聯電｜智財管理對公司治理的助益｜張振倫資深副總暨法務長，台灣智慧財產管理制度TIPS，上網日期2024年5月11日，檢自：https://www.youtube.com/watch?v=pITwSCG9Dfg
    經濟部產業發展署，(2024)，TIPS驗證通過名單，上網日期2024年6月14日，檢自：https://www.tips.org.tw/public/File/202406/20240603091106_3306639_C.pdf
    經濟部智慧財產局，(2018)，從iRobot掃地機大戰，看中小企業專利布局眉角！，經濟部智慧財產局專利商品化教育宣導網，上網日期2024年3月30日，檢自：https://pcm.tipo.gov.tw
    經濟部智慧財產局，(2021年9月)，商標法逐條釋義，上網日期2024年2月21日，檢自：https://topic.tipo.gov.tw/trademarks-tw/cp-514-896911-d731c-201.html
    經濟部智慧財產局專利主題網，(2022年4月29日)，智慧局110年報專利統計，上網日期2022年7月26日，檢自：https://topic.tipo.gov.tw
    經濟部智慧財產局，(2023)，小蝦米對抗大鯨魚－「老二哲學」的生存法則，，經濟部智慧財產局，專利商品化教育宣導網，上網日期2024年3月30日，檢自：https://pcm.tipo.gov.tw
    經濟部智慧財產局，(2024)，從iRobot掃地機大戰，看中小企業專利布局眉角！，經濟部智慧財產局，專利商品化教育宣導網，上網日期2024年3月30日，檢自：https://pcm.tipo.gov.tw
    群聯電子股份有限公司，(2024a)，關於群聯，上網日期2024年6月15日，檢自：https://www.phison.com/zh-tw/company/about
    群聯電子股份有限公司，(2024b年1月31日)，高解析度錄影時代來臨 群聯推出錄影與監控系統專用SSD，上網日期2024年6月27日，檢自：https://www.phison.com/zh-tw/category/article/press-releases/%E9%AB%98%E8%A7%A3%E6%9E%90%E5%BA%A6%E9%8C%84%E5%BD%B1%E6%99%82%E4%BB%A3%E4%BE%86%E8%87%A8-%E7%BE%A4%E8%81%AF%E6%8E%A8%E5%87%BA%E9%8C%84%E5%BD%B1%E8%88%87%E7%9B%A3%E6%8E%A7%E7%B3%BB%E7%B5%B1%E5%B0%88%E7%94%A8ssd
    群聯電子股份有限公司，(2024c年5月15日)，群聯電子推出企業級SSD品牌PASCARI及高階X200 SSD，上網日期2024年6月27日，檢自：https://www.phison.com/zh-tw/category/article/press-releases/%E7%BE%A4%E8%81%AF%E9%9B%BB%E5%AD%90%E6%8E%A8%E5%87%BA%E4%BC%81%E6%A5%AD%E7%B4%9Assd%E5%93%81%E7%89%8Cpascari%E5%8F%8A%E9%AB%98%E9%9A%8Ex200-ssd
    建省晉華集成電路有限公司，(2018a年1月19日)，晉華堅決捍衛自身權益，對美光侵權行為提起訴訟，上網日期2024年6月15日，檢自：https://www.jhicc.com/news.html?info=news5
    福建省晉華集成電路有限公司，(2018b年7月3日)，美光獲裁禁售部分產品，先行停止侵犯晉華專利權，上網日期2024年6月15日，檢自：https://www.jhicc.com/news.html?info=news4
    鄭淑芳，(2021年3月10日)，大立光、先進光 冤家變親家，工商時報，上網日期2024年5月16日，檢自：https://www.ctee.com.tw/news/20210310700150-430502
    華南國際知識產權研究院，(2018年5月15日)，iRobot與松騰實業侵犯發明專利權糾紛，廣東外語外貿大學，上網日期2024年4月23日，檢自：https://sciiip.gdufs.edu.cn/info/1028/1248.htm
    慶辰法律事務所，(2023年7月31日)，電子報，2023年8月第124期，上網日期2024年3月7日，檢自：https://www.chingcheng-law.com/post/90
    數位時代，(2005年7月15日)，全球遊戲機產業，火辣奔來！，上網日期2024年6月17日，檢自：https://www.bnext.com.tw/article/3964/BN-ARTICLE-3964?
    數位時代，(2021年4月6日)，甲骨文、Google十年恩怨落幕！90億美元Java案大翻盤，美最高法院判Android未侵權，上網日期2024年1月20日，檢自：https://www.bnext.com.tw/article/62139/google-v-oracle-supreme-court-declares-fair
    劉志原，(2021年10月24日)，前高階主管突認罪　聯電面臨美光求償，鏡週刊，上網日期2024年5月7日，檢自：https://www.mirrormedia.mg/story/20211019inv006
    劉芳妙，(2023年5月17日)，大立光專利戰 降服特斯拉，經濟日報，上網日期2023年8月21日，檢自：https://money.udn.com/money/story/5612/7170009
    劉芳妙，(2023年11月22日)，大立光打專利戰 再告玉晶光…外界解讀意在嗆聲蘋果，經濟日報，上網日期2023年12月26日，檢自：https://udn.com/news/story/7240/7589930
    滕淑芬，(2007年10月)，機器僕人上工了！，台灣光華雜誌，上網日期2024年4月23日，檢自：https://www.taiwanpanorama.com/Articles/Details?Guid=b1f320f4-d84e-4892-8e1c-6e9e38b183d9&CatId=9&postname=%E6%A9%9F%E5%99%A8%E5%83%95%E4%BA%BA%E4%B8%8A%E5%B7%A5%E4%BA%86%EF%BC%81
    韓婷婷，(2021年3月9日)，盤點 10 年法律戰，大立光林恩平將專利視為攻擊武器，中央社，上網日期2024年5月24日，檢自：https://www.cna.com.tw/news/afe/202103090344.aspx
    鍾張涵，(2020a年6月17日)，聯電官司敗訴背後　一批來自美國的神祕證據，天下雜誌，上網日期2024年5月11日，檢自：https://www.cw.com.tw/article/5100776?template=transformers
    鍾張涵，(2020b年12月17日)，獨家剖析聯電認罪協議 律師：有很大殺傷力，天下雜誌，上網日期2024年5月11日，檢自：https://www.cw.com.tw/article/5102595?from=search
    鍾張涵及陳良榕，(2020年10月31日)，兩份關鍵文件》業績亮眼，訴訟結果不錯，聯電股價為何大跌？，天下雜誌，上網日期2024年5月11日，檢自：https://www.cw.com.tw/article/5102540?template=transformers
    鍾張涵，(2021年4月14日)，「笨到」拿大立光機密申請專利？8年纏訟如何讓先進光變「小立光」，天下雜誌，上網日期2024年1月21日，檢自：https://www.cw.com.tw/article/5114372
    聯華電子股份有限公司，(2017a年2月22日)，公告本公司董事會決議解除經理人競業禁止之限制，重大訊息，公開資訊觀測站，上網日期2024年6月15日，檢自：https://mops.twse.com.tw/mops/web/t05st01
    聯華電子股份有限公司，(2017b年2月22日)，2016年年度年報，上網日期2024年5月9日，檢自：https://www.umc.com/upload/media/08_Investors/Annual_Reports/annual_report_chinese_pdf/2016/2016AR_CHI_all.pdf
    聯華電子股份有限公司，(2018a年1月12日)，本公司對美光半導體（西安）有限責任公司與美光半導體銷售（上海）有限公司等在大陸福州市中級人民法院提起侵害專利權訴訟，重大訊息，公開資訊觀測站，上網日期2024年5月9日，檢自：https://mops.twse.com.tw/mops/web/t05st01
    聯華電子股份有限公司，(2018b年7月3日)，大陸福州市中級人民法院對美光半導體銷售（上海）有限公司侵害本公司專利權作出民事裁定，重大訊息，公開資訊觀測站，上網日期2024年5月9日，檢自：https://mops.twse.com.tw/mops/web/t05st01
    聯華電子股份有限公司，(2018c年7月3日)，大陸福州市中級人民法院對美光半導體（西安）有限責任公司與美光半導體銷售（上海）有限公司侵害本公司專利權出民事裁定，重大訊息，公開資訊觀測站，上網日期2024年5月9日，檢自：https://mops.twse.com.tw/mops/web/t05st01
    聯華電子股份有限公司，(2018d年3月7日)，2017年年度年報，上網日期2024年5月9日，檢自：https://www.umc.com/upload/media/08_Investors/Annual_Reports/annual_report_chinese_pdf/2017/2017AR_CHI_all.pdf
    聯華電子股份有限公司，(2019年3月6日)，2018年年度年報，上網日期2024年5月9日，檢自：https://www.umc.com/upload/media/08_Investors/Annual_Reports/annual_report_chinese_pdf/2018/2018AR_CHI_all.pdf
    聯華電子股份有限公司，(2020a年2月26日)，2019年年度年報，上網日期2024年5月9日，檢自：https://www.umc.com/upload/media/08_Investors/Annual_Reports/annual_report_chinese_pdf/2019/2019AR_CHI_all.pdf
    聯華電子股份有限公司，(2020b年10月29日)，法院核准本公司與美國司法部間營業秘密刑事案件之和解協議，重大訊息，公開資訊觀測站，上網日期2024年5月10日，檢自：https://mops.twse.com.tw/mops/web/t05st01
    聯華電子股份有限公司，(2021年2月24日)，2020年年度年報，上網日期2024年5月9日，檢自：https://www.umc.com/upload/media/08_Investors/Annual_Reports/annual_report_chinese_pdf/2020/2020AR_CHI_all.pdf
    聯華電子股份有限公司，(2022年2月24日)，2021年年度年報，上網日期2024年5月9日，檢自：https://www.umc.com/upload/media/08_Investors/Annual_Reports/annual_report_chinese_pdf/2021/2021AR_CHI_all.pdf
    聯華電子股份有限公司，(2023年2月22日)，2022年年度年報，上網日期2024年5月9日，檢自：https://www.umc.com/upload/media/08_Investors/Annual_Reports/annual_report_chinese_pdf/2022/2022AR_CHI_all.pdf.pdf
    聯華電子股份有限公司，(2024a年1月2日)，聯華電子榮獲台灣智慧財產管理制度(TIPS)AAA最高等級認證，聯電新聞中心，上網日期2024年5月9日，檢自：https://www.umc.com/zh-TW/News/press_release/Content/corporate/20240102
    聯華電子股份有限公司，(2024b年2月27日)，2023年年度年報，上網日期2024年5月9日，檢自：https://www.umc.com/upload/media/08_Investors/Annual_Reports/annual_report_chinese_pdf/2023/2023AR_CHI_all.pdf
    謝福源，(2023年9月19日)，台積公司營業秘密智慧管理2.0，培育人才再創新，台灣積體電路製造股份有限公司 ESG，上網日期2024年4月12日，檢自：https://esg.tsmc.com/ch/update/innovationAndService/caseStudy/54/index.html
    顏雅娟，(2013年10月3日)，大立光為何不惜一戰要告倒先進光？，今周刊，第876期，上網日期2024年7月28日，檢自：https://www.businesstoday.com.tw/article/category/183008/post/201310030029/
    證券櫃檯買賣中心，(2024年1月25日)，昱展新藥生技股份有限公司(簡稱：昱展新藥，公司代號：6785)113年1月24日上櫃掛牌，上網日期2024年7月3日，檢自：https://www.tpex.org.tw/web/about/news/event/tpex_event_detail.php?l=zh-tw&doc_id=2326
    鏡週刊，2018年9月18日，小蝦米「掃」射大鯨魚 松騰實業董事長燕成祥，頭家開講，上網日期2024年3月19日，檢自：https://tw.news.yahoo.com/%E9%A0%AD%E5%AE%B6%E9%96%8B%E8%AC%9B-%E5%B0%8F%E8%9D%A6%E7%B1%B3-%E6%8E%83-%E5%B0%84%E5%A4%A7%E9%AF%A8%E9%AD%9A-%E6%9D%BE%E9%A8%B0%E5%AF%A6%E6%A5%AD%E8%91%A3%E4%BA%8B%E9%95%B7%E7%87%95%E6%88%90%E7%A5%A5-030000372.html
    饒秀珍，(2023年12年18日)，3項新藥8.6億美元入袋 創台灣生技授權最高紀錄！昱展「選題」鎖定買家贏在起跑點，財訊，第700期，上網日期2024年4月29日，檢自：https://www.wealth.com.tw/articles/22b585b3-596a-4f54-b37d-6699f57bc248
    寶齡富錦，(2014a年2月11日)，寶齡富錦腎臟新藥　獲日本上市許可，上網日期2024年7月2日，檢自：https://www.pbf.com.tw/blog/2014/01/17/%e5%af%b6%e9%bd%a1%e5%af%8c%e9%8c%a6%e8%85%8e%e8%87%9f%e6%96%b0%e8%97%a5%e3%80%8cnephoxil%e3%80%8d%e6%97%a5%e6%9c%ac%e5%90%88%e4%bd%9c%e5%a4%a5%e4%bc%b4jt-torii%e7%8d%b2%e6%97%a5%e6%9c%ac/
    寶齡富錦，(2014b年9月6日)，寶齡再創佳績，獲美FDA新藥上市許可，上網日期2024年7月2日，檢自：https://www.pbf.com.tw/blog/2014/09/06/%e5%af%b6%e9%bd%a1%e5%86%8d%e5%89%b5%e4%bd%b3%e7%b8%be%ef%bc%8c%e7%8d%b2%e7%be%8efda%e6%96%b0%e8%97%a5%e4%b8%8a%e5%b8%82%e8%a8%b1%e5%8f%af/
    寶齡富錦，(2015a年2月24日)，新春炮響 Nephoxil®中國市場起跑，上網日期2024年7月2日，檢自：https://www.pbf.com.tw/blog/2015/02/24/%E6%96%B0%E6%98%A5%E7%82%AE%E9%9F%BF-nephoxil%E4%B8%AD%E5%9C%8B%E5%B8%82%E5%A0%B4%E8%B5%B7%E8%B7%91/
    寶齡富錦，(2015a年2月24日)，寶齡拿百磷®正式取得衛福部新藥許可證，上網日期2024年7月2日，檢自：https://www.pbf.com.tw/blog/2015/04/29/%E5%AF%B6%E9%BD%A1%E6%8B%BF%E7%99%BE%E7%A3%B7%E6%AD%A3%E5%BC%8F%E5%8F%96%E5%BE%97%E8%A1%9B%E7%A6%8F%E9%83%A8%E6%96%B0%E8%97%A5%E8%A8%B1%E5%8F%AF%E8%AD%89/
    寶齡富錦，(2017年2月20日)，公告本公司與韓國協和醱酵麒麟公司（Kyowa Hakko Kirin Korea Co., Ltd.）簽署 授權與獨家經銷合約，上網日期2024年7月2日，檢自：https://www.pbf.com.tw/blog/2017/02/20/%e5%85%ac%e5%91%8a%e6%9c%ac%e5%85%ac%e5%8f%b8%e8%88%87%e9%9f%93%e5%9c%8b%e5%8d%94%e5%92%8c%e9%86%b1%e9%85%b5%e9%ba%92%e9%ba%9f%e5%85%ac%e5%8f%b8-%ef%bc%88kyowa-hakko-kirin-korea-co-ltd-%ef%bc%89/
    寶齡富錦，(2018年10月26日)，公告本公司與Keryx及Akebia簽署三方書面同意書-細節說明，上網日期2024年7月2日，檢自：https://www.pbf.com.tw/blog/2018/10/26/%e5%85%ac%e5%91%8a%e6%9c%ac%e5%85%ac%e5%8f%b8%e8%88%87keryx%e5%8f%8aakebia%e7%b0%bd%e7%bd%b2%e4%b8%89%e6%96%b9%e6%9b%b8%e9%9d%a2%e5%90%8c%e6%84%8f%e6%9b%b8-%e7%b4%b0%e7%af%80%e8%aa%aa%e6%98%8e/
    寶齡富錦，(2019a年4月16日)，公告本公司擬與Akebia簽署原Keryx授權合約之修訂與重述版本，上網日期2024年7月2日，檢自：https://www.pbf.com.tw/blog/2019/04/16/%e5%85%ac%e5%91%8a%e6%9c%ac%e5%85%ac%e5%8f%b8%e6%93%ac%e8%88%87akebia%e7%b0%bd%e7%bd%b2%e5%8e%9fkeryx%e6%8e%88%e6%ac%8a%e5%90%88%e7%b4%84%e4%b9%8b%e4%bf%ae%e8%a8%82%e8%88%87%e9%87%8d%e8%bf%b0%e7%89%88/
    寶齡富錦，(2019b年11月12日)，公告本公司擬與DKSH (Thailand) Limited簽署拿百磷 泰國獨家經銷合約，上網日期2024年7月2日，檢自：https://www.pbf.com.tw/blog/2019/11/12/%e5%85%ac%e5%91%8a%e6%9c%ac%e5%85%ac%e5%8f%b8%e6%93%ac%e8%88%87dksh-thailand-limited%e7%b0%bd%e7%bd%b2%e6%8b%bf%e7%99%be%e7%a3%b7-%e6%b3%b0%e5%9c%8b%e7%8d%a8%e5%ae%b6%e7%b6%93%e9%8a%b7%e5%90%88/
    寶齡富錦，(2022a年5月9日)，本公司腎臟新藥拿百磷 (Nephoxil) 韓國授權夥伴「Kyowa Hakko Kirin Korea Co., Ltd.」(以下簡稱為KKKR) 取得 NDA新藥進口上市許可，上網日期2024年7月2日，檢自：https://www.pbf.com.tw/blog/2022/05/10/111-05-10/
    寶齡富錦，(2022b年12月30日)，公告本公司美國授權夥伴Akebia Therapeutics與Averoa SAS簽署歐盟經濟區域獨家授權銷售合約，上網日期2024年7月2日，檢自：https://www.pbf.com.tw/blog/2022/12/30/111-12-30/
    寶齡富錦，(2023年5月1日)，111年度年報，上網日期2024年7月2日，檢自：https://drive.google.com/file/d/1eRp3BjcWFlzNTRzcgZx1yt17a7R-AzdE/view
    蘋果新聞網，(2018)，【與律師同行】侯慶辰雙證照前進中國　出奇招打敗知名藥廠，台灣蘋果日報，上網日期2024年3月6日，檢自：https://www.youtube.com/watch?v=jShSrE6_K34
    Description: 博士
    國立政治大學
    科技管理與智慧財產研究所
    104364503
    Source URI: http://thesis.lib.nccu.edu.tw/record/#G0104364503
    Data Type: thesis
    Appears in Collections:[Graduate Institute of TIPM] Theses

    Files in This Item:

    File SizeFormat
    450301.pdf6114KbAdobe PDF0View/Open


    All items in 政大典藏 are protected by copyright, with all rights reserved.


    社群 sharing

    著作權政策宣告 Copyright Announcement
    1.本網站之數位內容為國立政治大學所收錄之機構典藏，無償提供學術研究與公眾教育等公益性使用，惟仍請適度，合理使用本網站之內容，以尊重著作權人之權益。商業上之利用，則請先取得著作權人之授權。
    The digital content of this website is part of National Chengchi University Institutional Repository. It provides free access to academic research and public education for non-commercial use. Please utilize it in a proper and reasonable manner and respect the rights of copyright owners. For commercial use, please obtain authorization from the copyright owner in advance.

    2.本網站之製作，已盡力防止侵害著作權人之權益，如仍發現本網站之數位內容有侵害著作權人權益情事者，請權利人通知本網站維護人員(nccur@nccu.edu.tw)，維護人員將立即採取移除該數位著作等補救措施。
    NCCU Institutional Repository is made to protect the interests of copyright owners. If you believe that any material on the website infringes copyright, please contact our staff(nccur@nccu.edu.tw). We will remove the work from the repository and investigate your claim.
    DSpace Software Copyright © 2002-2004  MIT &  Hewlett-Packard  /   Enhanced by   NTU Library IR team Copyright ©   - Feedback